One World Products (OWPC) 10-K 14 Apr 22 2021 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2021	Apr. 12, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	000-56151
Entity Registrant Name	ONE WORLD PRODUCTS, INC.
Entity Central Index Key	0001622244
Entity Tax Identification Number	61-1744826
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3471 W. Oquendo Road
Entity Address, Address Line Two	Suite 301
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89118
City Area Code	(800)
Local Phone Number	605-3210
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 7,651,791
Entity Common Stock, Shares Outstanding		65,861,631
Documents Incorporated by Reference [Text Block]	None
ICFR Auditor Attestation Flag	false
Auditor Firm ID	2738
Auditor Name	M&K CPAS, PLLC
Auditor Location	Houston, TX

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 119,678	$ 28,920
Accounts receivable	19,880	5,636
Inventory	198,595	267,152
Other current assets	306,030	118,911
Total current assets	644,183	420,619
Right-of-use assets		195,029
Security deposits	1,255,988	65,114
Fixed assets, net	1,003,013	726,820
Total Assets	2,903,184	1,407,582
Current liabilities:
Accounts payable	480,146	734,554
Accrued expenses	457,762	550,535
Deferred revenues	30,164
Dividends payable	98,920	37,236
Current portion of lease liabilities		45,271
Convertible notes payable, net of $412,673 of debt discounts at December 31, 2021	337,327
Notes payable	119,274	334,841
Total current liabilities	1,523,593	1,702,437
Long-term lease liability		156,254
Notes payable, related party, long-term portion	200,000
Total Liabilities	1,723,593	1,858,691
Convertible preferred stock value
Stockholders’ Equity (Deficit):
Preferred stock, $0.001 par value, 9,500,000 shares authorized; no shares issued and outstanding at December 31, 2021 and 2020, respectively
Common stock, $0.001 par value, 300,000,000 shares authorized; 65,599,565 and 53,085,305 shares issued and outstanding at December 31, 2021 and 2020, respectively	65,600	53,085
Additional paid-in capital	16,843,656	14,103,672
Subscriptions payable, consisting of 262,066 and 750,000 shares at December 31, 2021 and 2020, respectively	21,725	75,000
Accumulated other comprehensive loss	(64,347)	(52,870)
Accumulated (deficit)	(19,916,888)	(16,132,326)
Total Stockholders’ Equity (Deficit)	(3,050,254)	(1,953,439)
Total Liabilities and Stockholders’ Equity (Deficit)	2,903,184	1,407,582
Series A Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	652,330	1,502,330
Series B Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	$ 3,577,515

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Convertible notes payable, debt discounts	$ 412,673
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	9,500,000	9,500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	65,599,565	53,085,305
Common stock, shares outstanding	65,599,565	53,085,305
Subscriptions payable, shares	262,066	750,000
Series A Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	500,000	500,000
Temporary equity, shares issued	65,233	150,233
Temporary equity, shares outstanding	65,233	150,233
Preferred stock, par value	$ 0.001
Preferred stock, shares authorized	10,000,000
Series B Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	300,000	300,000
Temporary equity, shares issued	238,501	0
Temporary equity, shares outstanding	238,501	0

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues	$ 38,264	$ 59,568
Cost of goods sold	19,744	104,729
Gross profit (loss)	18,520	(45,161)
Operating expenses:
General and administrative	2,294,284	3,960,791
Professional fees	915,217	3,878,006
Depreciation expense	40,321	33,610
Total operating expenses	3,249,822	7,872,407
Operating loss	(3,231,302)	(7,917,568)
Other income (expense):
Sublease income	27,000
Loss on disposal of fixed assets	(71,487)
Interest income	2,358
Interest expense	(511,131)	(47,592)
Total other expense	(553,260)	(47,592)
Net loss	(3,784,562)	(7,965,160)
Other comprehensive loss:
Loss on foreign currency translation	(11,477)	(36,622)
Net other comprehensive loss	(3,796,039)	(8,001,782)
Series A convertible preferred stock declared ($0.60 per share)	(61,684)	(37,236)
Deemed dividend on common stock warrants, series A preferred stock		(1,502,330)
Net loss attributable to common shareholders	$ (3,857,723)	$ (9,541,348)
Weighted average number of common shares outstanding - basic and fully diluted	60,600,548	48,829,160
Net loss per share - basic and fully diluted	$ (0.06)	$ (0.20)
Dividends declared per share of common stock	$ 0	$ 0

Consolidated Statements of Op_2

Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) - $ / shares	Dec. 31, 2021	Jul. 26, 2021	Dec. 31, 2020
Purchase price per share		$ 0.13
Series A Convertible Preferred Stock [Member]
Purchase price per share	$ 0.60		$ 0.60

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Series A Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscriptions Payable [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2019			$ 44,804	$ 8,150,004	$ 250,000	$ (16,248)	$ (8,167,166)	$ 261,394
Balance, shares at Dec. 31, 2019			44,804,305
Preferred stock units sold for cash	$ 1,502,330
Preferred stock units sold for cash, shares	150,233
Common stock sold for cash			$ 500	249,500	(175,000)			75,000
Common stock sold for cash, shares			500,000
Common stock issued for services			$ 7,781	3,570,719				3,578,500
Common stock issued for services, shares			7,781,000
Amortization of common stock options issued for services				2,170,685				2,170,685
Series A convertible preferred stock dividend declared ($0.60 per share)				(37,236)				(37,236)
Loss on foreign currency translation						(36,622)		(36,622)
Net loss							(7,965,160)	(7,965,160)
Balance at Dec. 31, 2020	$ 1,502,330		$ 53,085	14,103,672	75,000	(52,870)	(16,132,326)	(1,953,439)
Balance, shares at Dec. 31, 2020	150,233		53,085,305
Series B convertible preferred stock sold for cash to our CEO		$ 3,050,010
Series B convertible preferred stock sold for cash to our CEO, shares		203,334
Series B convertible preferred stock sold for cash		$ 527,505		(10)				(10)
Series B convertible preferred stock sold for cash, shares		35,167
Common stock sold for cash			$ 750	74,250	(75,000)
Common stock sold for cash, shares			750,000
Conversion of series A convertible preferred stock	$ (850,000)		$ 8,500	841,500				850,000
Conversion of series A convertible preferred stock, shares	(85,000)		8,500,000
Common stock issued for services			$ 955	111,075	21,725			133,755
Common stock issued for services, shares			954,260
Commitment shares issued pursuant to promissory note			$ 2,250	416,062				418,312
Commitment shares issued pursuant to promissory note, shares			2,250,000
Exercise of cashless options			$ 60	(60)
Exercise of cashless options, shares			60,000
Warrants issued as a debt discount				358,017				358,017
Amortization of common stock options issued for services				1,000,834				1,000,834
Series A convertible preferred stock dividend declared ($0.60 per share)				(61,684)				(61,684)
Loss on foreign currency translation						(11,477)		(11,477)
Net loss							(3,784,562)	(3,784,562)
Balance at Dec. 31, 2021	$ 652,330	$ 3,577,515	$ 65,600	$ 16,843,656	$ 21,725	$ (64,347)	$ (19,916,888)	$ (3,050,254)
Balance, shares at Dec. 31, 2021	65,233	238,501	65,599,565

Consolidated Statement of Sto_2

Consolidated Statement of Stockholders' Equity (Deficit) (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Series Convertible A Preferred Stock [Member]
Purchase price per share	$ 0.60	$ 0.60

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net loss	$ (3,784,562)	$ (7,965,160)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debts expense	2,062
Depreciation and amortization expense	40,321	33,610
Loss on disposal of fixed assets	71,487
Amortization of debt discounts	456,656
Stock-based compensation	133,755	3,578,500
Amortization of options issued for services	1,000,834	2,170,685
Decrease (increase) in assets:
Accounts receivable	(16,306)	(5,636)
Inventory	68,557	(242,470)
Other current assets	(187,119)	148,195
Right-of-use assets	195,029	307,677
Security deposits	(1,190,874)	7,413
Increase (decrease) in liabilities:
Accounts payable	(254,408)	404,031
Accrued expenses	(92,773)	440,870
Deferred revenues	30,164
Lease liability	(201,525)	(306,827)
Net cash used in operating activities	(3,728,702)	(1,429,112)
Cash flows from investing activities
Proceeds received on disposal of fixed assets	5,125
Purchase of fixed assets	(393,126)	(62,567)
Net cash used in investing activities	(388,001)	(62,567)
Cash flows from financing activities
Repayment of convertible note payable		(507,332)
Proceeds from notes payable	1,147,000	476,841
Repayment of notes payable	(505,567)	(272,000)
Proceeds from sale of preferred and common stock	3,577,505	1,577,332
Net cash provided by financing activities	4,218,938	1,274,841
Effect of exchange rate changes on cash	(11,477)	(36,622)
Net increase (decrease) in cash	90,758	(253,460)
Cash - beginning	28,920	282,380
Cash - ending	119,678	28,920
Supplemental disclosures:
Interest paid	48,252	22,002
Income taxes paid
Non-cash investing and financing transactions:
Cost of preferred shares exchanged for conversion to common stock	850,000
Value of commitment shares issued as a debt discount	418,312
Value of warrants issued as a debt discount	358,017
Dividends payable	61,684	37,236
Par value of cashless exercise of common stock options	$ 60

Nature of Business and Signific

Nature of Business and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Nature of Business and Significant Accounting Policies	Note 1 – Nature of Business and Significant Accounting Policies Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, One World Pharma, Inc. (“One World Pharma”) entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., our wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian company (“OWP Colombia”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP Colombia) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 n November 23, 2021, the Company changed its name to One World Products, Inc. through the merger of One World Products, Inc., a recently formed Nevada corporation wholly-owned by the Company, with and into the Company (the “Name Change Merger”) pursuant to the applicable provisions of the Nevada Revised Statutes (“NRS”). As permitted by the NRS, the articles of merger filed with the Secretary of State of the state of Nevada to effect the Name Change Merger amended Article I of the Company’s Articles of Incorporation to change the Company’s name to “One World Products, Inc.” The Name Change Merger was effected solely to effect the change of the Company’s name, and had no effect on the Company’s officers, directors, operations, assets or liabilities. OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP Colombia. OWP Colombia is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). We plan to be a producer of raw cannabis and hemp plant ingredients for both medical and industrial uses across the globe. We have received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, we are one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, we have entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members, under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. We began harvesting cannabis in the first quarter of 2019 for the purpose of further research and development activities, quality control testing and extraction. We have been generating revenue from the sale of our seeds since the second quarter of 2020. In August 2021, we paid total deposits of $ 1,155,000 1,400,000 Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”). All references to Generally Accepted Accounting Principles (“GAAP”) are in accordance with The FASB Accounting Standards Codification (“ASC”) and the Hierarchy of Generally Accepted Accounting Principles. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at December 31, 2021: Schedule of Common Control and Ownership Interest Name of Entity State of Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary One World Pharma S.A.S. (3) Colombia Subsidiary Colombian Hope, S.A.S. (4) Colombia Subsidiary Agrobase, S.A.S. (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its production efforts are within Popayán, Colombia. Foreign Currency Translation The functional currency of the Company is Columbian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods. Comprehensive Income The Company has adopted ASC 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Fair Value of Financial Instruments The Company adopted ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows: - Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. - Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. - Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement. The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short-term nature of the instruments. Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 no Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. Fixed Assets Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy: Schedule of Estimated Useful Lives of Fixed Assets Buildings 15 Office equipment 5 Furniture and fixtures 7 Equipment and machinery 7 Leasehold improvements Term of lease Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extended the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations. Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s sales to date have primarily consisted of the sale of seeds. These sales include multi-element arrangements whereby the Company collects 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company has a right of first refusal to purchase products resulting from the harvest. At December 31, 2021, the Company had $ 30,164 19,470 Advertising Costs The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $ 137,915 143,341 Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended December 31, 2021 and 2020, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share. Stock-Based Compensation The Company accounts for equity instruments issued in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Income Taxes The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not. Uncertain Tax Positions In accordance with ASC 740, “Income Taxes” (“ASC 740”), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities. The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions. Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2021, with early adoption permitted. The adoption of ASU 2020-06 is not expected to have a material impact on the Company’s financial statements or related disclosures. In May 2020, the SEC adopted final rules that amend the financial statement requirements for significant business acquisitions and dispositions. Among other changes, the final rules modify the significance tests and improve the disclosure requirements for acquired or to be acquired businesses and related pro forma financial information, the periods those financial statements must cover, and the form and content of the pro forma financial information. The final rules do not modify requirements for the acquisition and disposition of significant amounts of assets that do not constitute a business. The final rules were effective January 1, 2021. The Company has considered these final rules and updated its disclosures, as applicable. In November 2019, the FASB issued ASU 2019-12 – Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in ASU 2019-12 are part of an initiative to reduce complexity in accounting standards and simplify the accounting for income taxes by removing certain exceptions from Topic 740 and making minor improvements to the codification. ASU 2019 - There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2 – Going Concern As shown in the accompanying financial statements, the Company had $ 879,410 19,916,888 The financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company’s ability to continue as a going concern. These financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 3 – Related Party Transactions Advance from Vice Chairman of the Board On December 29, 2021, the Company received an advance of $ 200,000 January 1, 2024 8 Debt Repayments, Related Party On October 18, 2021, the Company repaid a total of $ 52,918 50,000 2,918 On September 15, 2021, the Company repaid a total of $ 130,610 125,000 5,610 On March 29, 2021, the Company repaid a total of $ 27,201 26,000 1,201 Advances and Repayment to former CEO On various dates between May 3, 2018 and November 23, 2018, our then CEO advanced us short-term unsecured demand loans, bearing interest at 6 514,141 200,000 400,000 307,141 6 5,000,000 307,141 13,791 200,000 400,000 Series A Preferred Stock Sales On July 10, 2020, the Company received proceeds of $ 110,000 11,000 five 50 0.25 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Series B Preferred Stock Sales On February 7, 2021, the Company and ISIAH International, LLC (“ISIAH International”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) under which ISIAH International agreed to purchase from the Company, on the dates provided for in the Purchase Agreement, an aggregate of 200,000 20,000,000 15 3 15 0.15 200,000 Schedule of Agreement to Purchase Shares of Preferred Stock Date Shares Purchase Price Initial Closing Date 16,666 $ 249,990 February 22, 2021 16,667 250,005 March 8, 2021 16,667 250,005 March 22, 2021 16,667 250,005 April 5, 2021 16,666 249,990 April 19, 2021 16,667 250,005 May 17, 2021 33,334 500,010 June 14, 2021 33,333 499,995 July 12, 2021 33,333 499,995 Total 200,000 $ 3,000,000 On various dates in May, 2021, the Company also received total proceeds of $ 50,010 3,334 15 Common Stock Issued for Services On December 31, 2021, the Company issued 673,582 The aggregate fair value of the shares was $ 55,234 On December 31, 2020, the Company awarded 750,000 90,000 On December 31, 2020, the Company awarded 750,000 90,000 On June 3, 2020, the Company awarded 500,000 275,000 On June 3, 2020, the Company awarded 2,000,000 1,100,000 On May 31, 2020, the Company awarded 350,000 196,000 Common Stock Options Issued for Services On May 28, 2021, the Company awarded options to purchase 1,000,000 0.1782 ten year 500,000 500,000 250,000 183 0.1719 171,949 171,949 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS On January 1, 2021, the Company awarded options to purchase 5,500,000 0.13 ten year 2,750,000 2,750,000 250,000 192 0.1174 645,624 410,853 234,771 On January 1, 2021, the Company awarded options to purchase 350,000 0.13 ten year 192 0.1170 40,943 40,943 On January 1, 2021, the Company awarded options to purchase 475,000 0.13 ten year 192 0.1170 55,565 55,565 On June 3, 2020, the Company awarded options to purchase 5,500,000 0.55 ten year 1,500,000 1,000,000 3,000,000 301 0.5499 3,024,689 1,206,933 On May 31, 2020, the Company awarded options to purchase 350,000 0.56 116,667 233,333 two years 302 0.5599 195,959 102,056 On May 31, 2020, the Company awarded options to purchase 350,000 0.56 116,667 233,333 two years 302 0.5599 195,959 102,056 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2021
Investments, All Other Investments [Abstract]
Fair Value of Financial Instruments	Note 4 – Fair Value of Financial Instruments Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value. The Company has certain financial instruments that must be measured under the new fair value standard. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balances sheet as of December 31, 2021 and 2020: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2021 Level 1 Level 2 Level 3 Assets Cash $ 119,678 $ - $ - Right-of-use-asset Total assets 119,678 - - Liabilities Convertible notes payable, net of $ 412,673 - 337,327 - Convertible notes payable - 319,274 - Lease liabilities Notes payable Total liabilities - (656,601 ) - Total assets and liabilities $ 119,678 $ (656,601 ) $ - Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2020 Level 1 Level 2 Level 3 Assets Cash $ 28,920 $ - $ - Right-of-use-asset - - 195,029 Total assets 28,920 - 195,029 Liabilities Lease liabilities - - 201,525 Notes payable - 334,841 - Total liabilities - (334,841 ) (201,525 ) Total assets and liabilities $ 28,920 $ (334,841 ) $ (6,496 ) There were no transfers of financial assets or liabilities between Level 1 and Level 2 inputs for the years ended December 31, 2021 or 2020. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Major Customers and Accounts Re

Major Customers and Accounts Receivable	12 Months Ended
	Dec. 31, 2021
Major Customers And Accounts Receivable
Major Customers and Accounts Receivable	Note 5 – Major Customers and Accounts Receivable The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows: For the year ended December 31, 2021, four customers accounted for 60% At December 31, 2021, one customer accounted for 75%

Inventory

Inventory	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Inventory	Note 6 – Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. Inventory consisted of the following at December 31, 2021 and 2020, respectively. Schedule of Inventory December 31, December 31, 2021 2020 Raw materials $ 31,233 $ 27,514 Work in progress 81,182 181,272 Finished goods 108,246 104,673 Inventory gross 220,661 313,459 Less obsolescence (22,066 ) (46,307 ) Total inventory $ 198,595 $ 267,152

Other Current Assets

Other Current Assets	12 Months Ended
	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Current Assets	Note 7 – Other Current Assets Other current assets included the following as of December 31, 2021 and 2020, respectively: Schedule of Other Current Assets December 31, December 31, 2021 2020 VAT tax receivable $ 147,194 $ 99,199 Prepaid expenses 29,366 19,226 Deferred cost of goods sold 19,470 - Other receivables 110,000 486 Total $ 306,030 $ 118,911

Security Deposits

Security Deposits	12 Months Ended
	Dec. 31, 2021
Security Deposits
Security Deposits	Note 8 – Security Deposits Security deposits included the following as of December 31, 2021 and 2020, respectively: Schedule of Security Deposits December 31, December 31, 2021 2020 Utility deposits $ 1,090 $ 660 Refundable deposit on equipment purchase 50,000 50,000 Down payment on distillation equipment 1,155,000 - Security deposits on leases held in Colombia 35,869 9,960 Security deposit on office lease 14,029 4,494 Security deposits $ 1,255,988 $ 65,114 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fixed Assets

Fixed Assets	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Fixed Assets	Note 9 – Fixed Assets Fixed assets consist of the following at December 31, 2021 and 2020, respectively: Schedule of Fixed Assets December 31, December 31, 2021 2020 Land $ 138,248 $ 138,248 Buildings 473,971 41,665 Office equipment 56,502 44,027 Furniture and fixtures 34,409 27,914 Equipment and machinery 383,829 185,169 Construction in progress - 345,036 Fixed assets, gross 1,086,959 782,059 Less: accumulated depreciation (83,946 ) (55,239 ) Total $ 1,003,013 $ 726,820 Construction in progress consisted of equipment and capital improvements on the Popayán farm that were not placed in service until the year ended December 31, 2021. On November 30, 2021, the Company disposed of a building that was damaged in a storm at the Popayán farm. No 53,925 On July 27, 2021, the Company sold a truck previously used at the Popayán farm. The Company received proceeds of $ 5,125 2,064 On July 1, 2021, the Company disposed of equipment used at the Popayán farm that is no longer in service. No 15,498 Depreciation and amortization expense totaled $ 40,321 33,610

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued Expenses	Note 10 – Accrued Expenses Accrued expenses consisted of the following at December 31, 2021 and 2020, respectively: Schedule of Accrued Expenses December 31, December 31, 2021 2020 Accrued payroll $ 261,044 $ 266,230 Accrued withholding taxes and employee benefits 9,162 18,889 Accrued ICA fees and contributions 129,856 200,335 Accrued interest 57,700 65,081 Accrued expenses $ 457,762 $ 550,535

Deferred Revenues

Deferred Revenues	12 Months Ended
	Dec. 31, 2021
Deferred Revenues
Deferred Revenues	Note 11 – Deferred Revenues Arrangements with customers include multiple deliverables, consisting of an initial delivery of seeds and a contingent portion of the sale that is dependent on the customers future harvest of the seeds. Deferred revenues associated with these multiple-element arrangements were $ 30,164 19,470 10,964 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Leases
Leases	Note 12 – Leases The Company’s corporate offices and operational facility in Colombia under short-term non-cancelable real property lease agreements that expire within a year. The Company doesn’t have any other office or equipment leases subject to the recently adopted ASU 2016-02. In the locations in which it is economically feasible to continue to operate, management expects that lease options will be exercised. The Company’s corporate office is under a real property lease that contains a one-time renewal option for an additional 36 months that was amended to enable the Company to extend the lease for 12 months instead of 36 months. The Company is reasonably certain that it will not extend the lease beyond its extended term of October 31, 2022. The office lease contains provisions requiring payment of property taxes, utilities, insurance, maintenance and other occupancy costs applicable to the leased premise. As the Company’s leases do not provide an implicit discount rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The components of lease expense were as follows: Schedule of Components of Lease Expense For the Year Ended December 31, 2021 Operating lease cost: Amortization of assets $ 87,276 Interest on lease liabilities 3,035 Total lease cost $ 90,311 Supplemental cash flow and other information related to leases was as follows: Schedule of Supplemental Cash Flow Related to Leases For the Year Ended December 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 201,525

Convertible Note Payable

Convertible Note Payable	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Convertible Note Payable	Note 13 – Convertible Note Payable Convertible note payable consists of the following at December 31, 2021 and 2020, respectively: Schedule of Convertible Note Payable December 31, December 31, 2021 2020 $ 750,000 $ - On September 24, 2021, the Company completed the sale of a (i) Promissory Note in the principal amount of $ 750,000 three 1,500,000 0.25 three 2,000,000 0.50 705,000 678,750 45,000 15,000 11,250 September 24, 2022 8 20 250,000 1,250,000 150,062 $ 750,000 $ - Total convertible notes payable 750,000 - Less: unamortized debt discounts 412,673 - Convertible note payable, net of discounts $ 337,327 $ - ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The Company recognized debt discounts for the years ended December 31, 2021 and 2020, as follows: Schedule of Convertible Debt Discounts December 31, December 31, 2021 2020 Fair value of 3,250,000 $ 418,312 $ - Fair value of warrants to purchase 3,500,000 358,017 - Original issue discounts 53,700 - Legal and brokerage fees 39,300 - Total debt discounts 869,329 - Amortization of debt discounts 456,656 - Unamortized debt discounts $ 412,673 $ - The aggregate debt discounts of $ 869,329 456,656 The convertible note limits the maximum number of shares that can be owned by the note holder as a result of the conversions to common stock to 4.99 The Company recorded interest expense pursuant to the stated interest rates on the convertible notes in the amount of $ 36,243 21,516 456,656

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2021
Notes Payable
Notes Payable	Note 14 – Notes Payable Notes payable consists of the following at December 31, 2021 and 2020, respectively: Schedule of Notes Payable December 31, December 31, 2021 2020 $ 200,000 $ - On December 29, 2021, the Company received an advance of $ 200,000 January 1, 2024 8 $ 200,000 $ - On January 20, 2021, the Company completed the sale of a Promissory Note in the principal amount of $ 290,000 281,300 268,250 8,700 7,250 5,800 The First AJB Note carried interest at a rate of 10 October 20, 2021 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 200,000 2,000,000 As the Company repaid the First AJB Note prior to the Maturity Date, the Company exercised its right to redeem 1,000,000 of the Commitment Fee Shares for a nominal redemption price of $1.00. The issuance of the Commitment Fee Shares resulted in a debt discount of $ 268,250 - - On February 3, 2020, the Company, through its wholly-owned subsidiary, One World Pharma SAS, received an advance of 100,000,000 29,134 6 50,000,000 14,567 50,000,000 14,567 - 14,567 On December 16, 2020, the Company received an advance of $ 125,000 6 130,610 125,000 5,610 - 125,000 On October 28, 2020, the Company received an advance of $ 50,000 6 52,918 50,000 2,918 October 18, 2021 - 50,000 On September 14, 2020, the Company received an advance of $ 26,000 6 March 29, 2021 - 26,000 On May 4, 2020, the Company, through its wholly-owned subsidiary OWP Ventures, Inc., borrowed $ 119,274 1.00 May 4, 2022 Under the Payroll Protection Program, the Company was eligible for loan forgiveness up to the full amount of the PPP Note and any accrued interest. The forgiveness amount was equal to the amount that the Company spent during the 24-week period beginning May 4, 2020 on payroll costs, payment of rent on any leases in force prior to February 15, 2020 and payment on any utility for which service began before February 15, 2020. The maximum amount of loan forgiveness for non-payroll expenses was 40 121,372 119,274 2,098 February 11, 2022 119,274 119,274 Total notes payable 319,274 334,841 Less: current maturities 119,274 334,841 Notes payable, long-term potion $ 200,000 $ - ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The Company recorded interest expense in the amount of $ 28,674 9,734 9,729 The Company recognized interest expense for the year ended December 31, 2021 and 2020, respectively, as follows: Schedule of Interest Expenses December 31, December 31, 2021 2020 Interest on convertible notes $ 17,260 $ 21,516 Interest on notes payable 28,674 9,734 Amortization of debt discounts 42,247 - Amortization of stock-based debt discounts 414,409 - Interest on accounts payable 8,541 16,342 Total interest expense $ 511,131 $ 47,592

Convertible Preferred Stock

Convertible Preferred Stock	12 Months Ended
	Dec. 31, 2021
Convertible Preferred Stock
Convertible Preferred Stock	Note 15 – Convertible Preferred Stock Preferred Stock The Company has 10,000,000 0.001 500,000 300,000 The shares of Series A Preferred Stock and Series B Preferred Stock are each currently convertible into one hundred (100) shares of the Company’s common stock 6 65,233 238,501 10 15 The Series A and B Preferred Stock have been classified outside of permanent equity and liabilities. the Series A Preferred Stock embodies conditional obligations that the Company may settle by issuing a variable number of equity shares, and in both the Series A and B Preferred Stock, monetary value of the obligation is based on a fixed monetary amount known at inception. Series A Preferred Stock Sales No On various dates between April 14, 2020 and October 28, 2020, the Company received total proceeds of $ 1,502,330 150,233 150,233 five 7,511,650 0.25 Series A Preferred Stock Conversions On November 15, 2021, a shareholder converted 30,000 3,000,000 On April 6, 2021, a shareholder converted 30,000 3,000,000 On March 24, 2021, a shareholder converted 10,000 1,000,000 On January 26, 2021, a shareholder converted 5,000 500,000 On January 12, 2021, a shareholder converted 10,000 1,000,000 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Preferred Stock Dividends The Series A Preferred Stock accrues dividends at the rate of 6 61,684 37,236 98,920 Series B Preferred Stock Sales On February 7, 2021, the Company and ISIAH International entered into a Securities Purchase Agreement under which ISIAH International agreed to purchase from the Company, on the dates provided for in the Purchase Agreement, an aggregate of 200,000 20,000,000 15 3 15 0.15 200,000 Schedule to Purchase Shares of Preferred Stock Date Shares Purchase Price Initial Closing Date 16,666 $ 249,990 February 22, 2021 16,667 250,005 March 8, 2021 16,667 250,005 March 22, 2021 16,667 250,005 April 5, 2021 16,666 249,990 April 19, 2021 16,667 250,005 May 17, 2021 33,334 500,010 June 14, 2021 33,333 499,995 July 12, 2021 33,333 499,995 Total 200,000 $ 3,000,000 In addition to the shares sold to ISIAH International, the Company received total proceeds of $ 527,520 35,167 15 50,010 3,334 15 No shares of Series B Preferred Stock were sold during the year ended December 31, 2020.

Stockholders_ Equity

Stockholders’ Equity	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Stockholders’ Equity	Note 16 – Stockholders’ Equity Preferred Stock The Company has 10,000,000 authorized shares of $ 0.001 par value “blank check” preferred stock, of which 500,000 shares have been designated Series A Preferred Stock and 300,000 shares have been designated Series B Preferred Stock, See Note 15 above for a description of the features and issuances of the Series A Preferred Stock and Series B Preferred Stock. Common Stock The Company is authorized to issue an aggregate of 300,000,000 0.001 65,599,565 Common Stock Options Exercised On July 26, 2021, a total of 60,000 125,000 0.13 Common Stock Sales No shares of common stock were sold during the year ended December 31, 2021. On November 27, 2020, the Company sold an aggregate of 750,000 0.10 75,000 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Common Stock Issued on Subscriptions Payable On January 6, 2020, the Company issued 500,000 0.50 25,000 Common Stock Issued as a Promissory Note Commitment As disclosed in Note 14 above, the Company paid a commitment fee to AJB Capital of $ 200,000 in the form of 2,000,000 shares of the Company’s common stock in connection with the issuance of the First AJB Note, which was repaid on September 17, 2021. The issuance of the commitment fee shares resulted in a debt discount of $ 268,250 that was amortized over the life of the loan, resulting in $ 268,250 of finance expense during the year ended December 31, 2021. On October 15, 2021, pursuant to the early repayment terms of the promissory note, one million of these shares were redeemed and cancelled for a nominal aggregate purchase price of $ 1.00 . Also, as disclosed in Note 13, above, the Company paid a commitment fee to AJB Capital in the form of 1,250,000 shares of the Company’s common stock in connection with the issuance of the Second AJB Note. The issuance of these commitment fee shares resulted in a debt discount of $ 150,062 that is being amortized over the life of the loan, resulting in $ 43,168 of finance expense during the year ended December 31, 2021. Common Stock Issued for Services, Employees and Consultants On May 25, 2021, the Company awarded a total of 50,000 The aggregate fair value of the shares was $ 8,500 On August 20, 2019, the Company engaged COR Prominence, LLC (“COR”) to provide investor relation services to the Company, in consideration for the payment of $ 7,500 5,000 118,150 The fair value of the shares was $ 29,538 On June 1, 2021, the Company entered into a new agreement with COR and issued another 112,528 The fair value of the shares was $ 18,758 262,066 The fair value of the shares was $ 21,725 On December 31, 2020, the Company awarded 100,000 12,000 On September 21, 2020, the Company awarded 250,000 45,000 On July 1, 2020, the Company awarded an aggregate of 875,000 332,500 On June 3, 2020, the Company awarded 200,000 120,000 On various dates between January 4, 2020 and May 31, 2020, the Company awarded an aggregate of 2,006,000 1,318,000 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Common Stock Issued for Services, Officers and Directors On December 31, 2021, the Company issued 673,582 The aggregate fair value of the shares was $ 55,234 On December 31, 2020, the Company awarded 750,000 90,000 On December 31, 2020, the Company awarded 750,000 90,000 On June 3, 2020, the Company awarded 500,000 275,000 On June 3, 2020, the Company awarded 2,000,000 1,100,000 On May 31, 2020, the Company awarded 350,000 196,000

Common Stock Options

Common Stock Options	12 Months Ended
	Dec. 31, 2021
Common Stock Options
Common Stock Options	Note 17 – Common Stock Options Stock Incentive Plan On February 12, 2020, the Company’s stockholders approved our 2019 Stock Incentive Plan (the “2019 Plan”), which had been adopted by the Company’s Board of Directors (the “Board”) as of December 10, 2019. The 2019 Plan provides for the issuance of up to 10,000,000 Common Stock Options Issued for Services On May 28, 2021, the Company awarded options to purchase 1,000,000 0.1782 ten year 500,000 500,000 250,000 183 0.1719 171,949 171,949 On May 25, 2021, the Company awarded options to purchase an aggregate 425,000 0.17 ten year 183 0.1653 70,269 20,493 49,776 On January 1, 2021, the Company awarded options to purchase 5,500,000 0.13 ten year 2,750,000 2,750,000 250,000 192 0.1174 645,624 410,853 234,771 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS On January 1, 2021, the Company awarded options to purchase 350,000 0.13 ten year 192 0.1170 40,943 40,943 On January 1, 2021, the Company awarded options to purchase 475,000 0.13 ten year 192 0.1170 55,565 55,565 On January 1, 2021, the Company awarded options to purchase an aggregate 1,842,000 0.13 ten year 192 0.1170 215,475 215,475 On December 31, 2020, the Company awarded options to purchase 250,000 0.13 192 0.1170 29,245 29,245 On December 31, 2020, the Company awarded options to purchase 125,000 0.13 192 0.1170 14,622 14,622 On December 31, 2020, the Company awarded options to purchase 50,000 0.13 192 0.1170 5,849 5,849 On July 1, 2020, the Company awarded options to purchase 125,000 0.38 ten year 303 0.3798 47,476 47,476 On July 1, 2020, the Company awarded options to purchase 1,000,000 0.38 ten year 303 0.38 379,958 63,326 On July 1, 2020, the Company awarded options to purchase 125,000 0.38 ten year 303 0.3799 47,482 23,742 23,742 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS On June 3, 2020, the Company awarded options to purchase 5,500,000 0.55 ten year 1,500,000 1,000,000 3,000,000 301 0.5499 3,024,689 1,206,933 On May 31, 2020, the Company awarded options to purchase 350,000 0.56 116,667 233,333 302 0.5599 195,959 102,056 On May 31, 2020, the Company awarded options to purchase 350,000 0.56 116,667 233,333 302 0.5599 195,959 102,056 On May 31, 2020, the Company awarded options to purchase an aggregate 1,900,000 0.56 633,333 1,266,667 302 0.5599 1,063,879 458,058 On May 31, 2020, the Company awarded options to purchase an aggregate 100,000 0.56 33,333 66,667 302 0.5599 55,994 12,100 25,760 18,134 Common Stock Options Exercised On July 26, 2021, a total of 60,000 125,000 0.13 The following is a summary of information about the Stock Options outstanding at December 31, 2021. Schedule of Option Exercise Price Range Shares Underlying Shares Underlying Options Outstanding Options Exercisable Weighted Shares Average Weighted Shares Weighted Underlying Remaining Average Underlying Average Range of Options Contractual Exercise Options Exercise Exercise Prices Outstanding Life Price Exercisable Price $ 0.13 0.56 10,742,000 8.63 $ 0.16 7,467,612 $ 0.17 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The following is a summary of activity of outstanding stock options: Schedule of Option Activity Weighted Average Number Exercise of Shares Prices Balance, December 31, 2019 766,669 $ 0.50 Options granted 9,875,000 0.51 Options exercised (9,366,669 ) (0.53 ) Balance, December 31, 2020 1,275,000 0.36 Options granted 9,592,000 0.14 Options exercised (125,000 ) (0.13 ) Balance, December 31, 2021 10,742,000 $ 0.16 Exercisable, December 31, 2021 7,467,612 $ 0.17

Common Stock Warrants

Common Stock Warrants	12 Months Ended
	Dec. 31, 2021
Common Stock Warrants
Common Stock Warrants	Note 18 – Common Stock Warrants Warrants to purchase a total of 11,011,650 On September 24, 2021, the Company completed the sale of a (i) Promissory Note in the principal amount of $ 750,000 three 1,500,000 0.25 three 2,000,000 0.50 705,000 197 0.1023 358,017 102,991 255,026 On various dates between April 14, 2020 and October 28, 2020, the Company received total proceeds of $ 1,502,330 150,233 150,233 five 7,511,650 0.25 305 0.2882 2,164,995 The following is a summary of information about our warrants to purchase common stock outstanding at December 31, 2021. Schedule of Warrants to Purchase Common Stock Outstanding Shares Underlying Shares Underlying Warrants Outstanding Warrants Exercisable Weighted Shares Average Weighted Shares Weighted Range of Underlying Remaining Average Underlying Average Exercise Warrants Contractual Exercise Warrants Exercise Prices Outstanding Life Price Exercisable Price $ 0.25 0.50 11,011,650 3.31 $ 0.25 0.50 11,011,650 $ 0.25 0.50 The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan: Schedule of Fair value Assumption of Warrants December 31, December 31, 2021 2020 Average risk-free interest rates 0.47 % 0.30 % Average expected life (in years) 3.00 5.00 Volatility 197 % 305 % ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The weighted average fair value of warrants granted with exercise prices at the current fair value of the underlying stock was approximately $ 0.10 0.25 The following is a summary of activity of outstanding common stock warrants: Schedule of Warrants Activity Weighted Average Number Exercise of Shares Prices Balance, December 31, 2019 - $ - Warrants granted 7,511,650 0.25 Balance, December 31, 2020 7,511,650 0.25 Warrants granted 3,500,000 0.39 Balance, December 31, 2021 11,011,650 $ 0.30 Exercisable, December 31, 2021 11,011,650 $ 0.30

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 19 – Commitments and Contingencies Legal Contingencies There are no material pending legal proceedings to which we are a party or to which any of our property is subject, nor are there any such proceedings known to be contemplated by governmental authorities. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Tax	Note 20 - Income Tax The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. For the years ended December 31, 2021 and 2020, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At December 31, 2021, the Company had approximately $ 7,309,000 The net operating loss carry forwards, if not utilized, will begin to expire in 2025. The provision (benefit) for income taxes for the years ended December 31, 2021 and 2020 were assuming a 21 Schedule of Effective Income Tax Rate 2021 2020 December 31, 2021 2020 Federal statutory income tax rate 21 % 21 % State income taxes - % - % Change in valuation allowance (21 )% (21 )% Net effective income tax rate - - ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The components of the Company’s deferred tax asset are as follows: Schedule of Deferred Tax Asset 2021 2020 December 31, 2021 2020 Deferred tax assets: Net operating loss carry forwards $ 1,535,000 $ 1,302,000 Net deferred tax assets before valuation allowance $ 1,535,000 $ 1,302,000 Less: Valuation allowance (1,535,000 ) (1,302,000 ) Net deferred tax assets $ - $ - Based on the available objective evidence, including the Company’s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at December 31, 2021 and 2020, respectively. In accordance with FASB ASC 740, the Company has evaluated its tax positions and determined there are no uncertain tax positions.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 21 – Subsequent Events Debt Financing On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 January 1, 2024 8 On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 January 1, 2024 8 Common Stock Issued on Subscriptions Payable On March 29, 2022, the Company issued 262,066 Lease Commitment On January 1, 2022, OWP Colombia entered into a lease for a warehouse over a ten 38,750 57,339,000 15,290 commence January 1, 2022 for a ten-year term that carries automatic options to extend for successive terms of five (5) years, as long as neither party has given notice of termination at least six (6) months in advance.

Nature of Business and Signif_2

Nature of Business and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Nature of Business	Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, One World Pharma, Inc. (“One World Pharma”) entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., our wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian company (“OWP Colombia”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP Colombia) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 n November 23, 2021, the Company changed its name to One World Products, Inc. through the merger of One World Products, Inc., a recently formed Nevada corporation wholly-owned by the Company, with and into the Company (the “Name Change Merger”) pursuant to the applicable provisions of the Nevada Revised Statutes (“NRS”). As permitted by the NRS, the articles of merger filed with the Secretary of State of the state of Nevada to effect the Name Change Merger amended Article I of the Company’s Articles of Incorporation to change the Company’s name to “One World Products, Inc.” The Name Change Merger was effected solely to effect the change of the Company’s name, and had no effect on the Company’s officers, directors, operations, assets or liabilities. OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP Colombia. OWP Colombia is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). We plan to be a producer of raw cannabis and hemp plant ingredients for both medical and industrial uses across the globe. We have received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, we are one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, we have entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members, under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. We began harvesting cannabis in the first quarter of 2019 for the purpose of further research and development activities, quality control testing and extraction. We have been generating revenue from the sale of our seeds since the second quarter of 2020. In August 2021, we paid total deposits of $ 1,155,000 1,400,000
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”). All references to Generally Accepted Accounting Principles (“GAAP”) are in accordance with The FASB Accounting Standards Codification (“ASC”) and the Hierarchy of Generally Accepted Accounting Principles. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at December 31, 2021: Schedule of Common Control and Ownership Interest Name of Entity State of Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary One World Pharma S.A.S. (3) Colombia Subsidiary Colombian Hope, S.A.S. (4) Colombia Subsidiary Agrobase, S.A.S. (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its production efforts are within Popayán, Colombia.
Foreign Currency Translation	Foreign Currency Translation The functional currency of the Company is Columbian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods.
Comprehensive Income	Comprehensive Income The Company has adopted ASC 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Segment Reporting	Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company adopted ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows: - Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. - Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. - Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement. The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short-term nature of the instruments.
Cash in Excess of FDIC Insured Limits	Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 no
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts.
Fixed Assets	Fixed Assets Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy: Schedule of Estimated Useful Lives of Fixed Assets Buildings 15 Office equipment 5 Furniture and fixtures 7 Equipment and machinery 7 Leasehold improvements Term of lease Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extended the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s sales to date have primarily consisted of the sale of seeds. These sales include multi-element arrangements whereby the Company collects 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company has a right of first refusal to purchase products resulting from the harvest. At December 31, 2021, the Company had $ 30,164 19,470
Advertising Costs	Advertising Costs The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $ 137,915 143,341
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended December 31, 2021 and 2020, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.
Income Taxes	Income Taxes The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not.
Uncertain Tax Positions	Uncertain Tax Positions In accordance with ASC 740, “Income Taxes” (“ASC 740”), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities. The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions.
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2021, with early adoption permitted. The adoption of ASU 2020-06 is not expected to have a material impact on the Company’s financial statements or related disclosures. In May 2020, the SEC adopted final rules that amend the financial statement requirements for significant business acquisitions and dispositions. Among other changes, the final rules modify the significance tests and improve the disclosure requirements for acquired or to be acquired businesses and related pro forma financial information, the periods those financial statements must cover, and the form and content of the pro forma financial information. The final rules do not modify requirements for the acquisition and disposition of significant amounts of assets that do not constitute a business. The final rules were effective January 1, 2021. The Company has considered these final rules and updated its disclosures, as applicable. In November 2019, the FASB issued ASU 2019-12 – Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in ASU 2019-12 are part of an initiative to reduce complexity in accounting standards and simplify the accounting for income taxes by removing certain exceptions from Topic 740 and making minor improvements to the codification. ASU 2019 - There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

Nature of Business and Signif_3

Nature of Business and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of Common Control and Ownership Interest	The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at December 31, 2021: Schedule of Common Control and Ownership Interest Name of Entity State of Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary One World Pharma S.A.S. (3) Colombia Subsidiary Colombian Hope, S.A.S. (4) Colombia Subsidiary Agrobase, S.A.S. (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.
Schedule of Estimated Useful Lives of Fixed Assets	Schedule of Estimated Useful Lives of Fixed Assets Buildings 15 Office equipment 5 Furniture and fixtures 7 Equipment and machinery 7 Leasehold improvements Term of lease

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Schedule of Agreement to Purchase Shares of Preferred Stock	Schedule of Agreement to Purchase Shares of Preferred Stock Date Shares Purchase Price Initial Closing Date 16,666 $ 249,990 February 22, 2021 16,667 250,005 March 8, 2021 16,667 250,005 March 22, 2021 16,667 250,005 April 5, 2021 16,666 249,990 April 19, 2021 16,667 250,005 May 17, 2021 33,334 500,010 June 14, 2021 33,333 499,995 July 12, 2021 33,333 499,995 Total 200,000 $ 3,000,000

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Investments, All Other Investments [Abstract]
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis	The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balances sheet as of December 31, 2021 and 2020: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2021 Level 1 Level 2 Level 3 Assets Cash $ 119,678 $ - $ - Right-of-use-asset Total assets 119,678 - - Liabilities Convertible notes payable, net of $ 412,673 - 337,327 - Convertible notes payable - 319,274 - Lease liabilities Notes payable Total liabilities - (656,601 ) - Total assets and liabilities $ 119,678 $ (656,601 ) $ - Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2020 Level 1 Level 2 Level 3 Assets Cash $ 28,920 $ - $ - Right-of-use-asset - - 195,029 Total assets 28,920 - 195,029 Liabilities Lease liabilities - - 201,525 Notes payable - 334,841 - Total liabilities - (334,841 ) (201,525 ) Total assets and liabilities $ 28,920 $ (334,841 ) $ (6,496 )

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Schedule of Inventory	Schedule of Inventory December 31, December 31, 2021 2020 Raw materials $ 31,233 $ 27,514 Work in progress 81,182 181,272 Finished goods 108,246 104,673 Inventory gross 220,661 313,459 Less obsolescence (22,066 ) (46,307 ) Total inventory $ 198,595 $ 267,152

Other Current Assets (Tables)

Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets	Other current assets included the following as of December 31, 2021 and 2020, respectively: Schedule of Other Current Assets December 31, December 31, 2021 2020 VAT tax receivable $ 147,194 $ 99,199 Prepaid expenses 29,366 19,226 Deferred cost of goods sold 19,470 - Other receivables 110,000 486 Total $ 306,030 $ 118,911

Security Deposits (Tables)

Security Deposits (Tables)	12 Months Ended
	Dec. 31, 2021
Security Deposits
Schedule of Security Deposits	Security deposits included the following as of December 31, 2021 and 2020, respectively: Schedule of Security Deposits December 31, December 31, 2021 2020 Utility deposits $ 1,090 $ 660 Refundable deposit on equipment purchase 50,000 50,000 Down payment on distillation equipment 1,155,000 - Security deposits on leases held in Colombia 35,869 9,960 Security deposit on office lease 14,029 4,494 Security deposits $ 1,255,988 $ 65,114

Fixed Assets (Tables)

Fixed Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	Fixed assets consist of the following at December 31, 2021 and 2020, respectively: Schedule of Fixed Assets December 31, December 31, 2021 2020 Land $ 138,248 $ 138,248 Buildings 473,971 41,665 Office equipment 56,502 44,027 Furniture and fixtures 34,409 27,914 Equipment and machinery 383,829 185,169 Construction in progress - 345,036 Fixed assets, gross 1,086,959 782,059 Less: accumulated depreciation (83,946 ) (55,239 ) Total $ 1,003,013 $ 726,820

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consisted of the following at December 31, 2021 and 2020, respectively: Schedule of Accrued Expenses December 31, December 31, 2021 2020 Accrued payroll $ 261,044 $ 266,230 Accrued withholding taxes and employee benefits 9,162 18,889 Accrued ICA fees and contributions 129,856 200,335 Accrued interest 57,700 65,081 Accrued expenses $ 457,762 $ 550,535

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases
Schedule of Components of Lease Expense	The components of lease expense were as follows: Schedule of Components of Lease Expense For the Year Ended December 31, 2021 Operating lease cost: Amortization of assets $ 87,276 Interest on lease liabilities 3,035 Total lease cost $ 90,311
Schedule of Supplemental Cash Flow Related to Leases	Supplemental cash flow and other information related to leases was as follows: Schedule of Supplemental Cash Flow Related to Leases For the Year Ended December 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 201,525

Convertible Note Payable (Table

Convertible Note Payable (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Convertible Note Payable	Convertible note payable consists of the following at December 31, 2021 and 2020, respectively: Schedule of Convertible Note Payable December 31, December 31, 2021 2020 $ 750,000 $ - On September 24, 2021, the Company completed the sale of a (i) Promissory Note in the principal amount of $ 750,000 three 1,500,000 0.25 three 2,000,000 0.50 705,000 678,750 45,000 15,000 11,250 September 24, 2022 8 20 250,000 1,250,000 150,062 $ 750,000 $ - Total convertible notes payable 750,000 - Less: unamortized debt discounts 412,673 - Convertible note payable, net of discounts $ 337,327 $ -
Schedule of Convertible Debt Discounts	The Company recognized debt discounts for the years ended December 31, 2021 and 2020, as follows: Schedule of Convertible Debt Discounts December 31, December 31, 2021 2020 Fair value of 3,250,000 $ 418,312 $ - Fair value of warrants to purchase 3,500,000 358,017 - Original issue discounts 53,700 - Legal and brokerage fees 39,300 - Total debt discounts 869,329 - Amortization of debt discounts 456,656 - Unamortized debt discounts $ 412,673 $ -

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Payable
Schedule of Notes Payable	Notes payable consists of the following at December 31, 2021 and 2020, respectively: Schedule of Notes Payable December 31, December 31, 2021 2020 $ 200,000 $ - On December 29, 2021, the Company received an advance of $ 200,000 January 1, 2024 8 $ 200,000 $ - On January 20, 2021, the Company completed the sale of a Promissory Note in the principal amount of $ 290,000 281,300 268,250 8,700 7,250 5,800 The First AJB Note carried interest at a rate of 10 October 20, 2021 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 200,000 2,000,000 As the Company repaid the First AJB Note prior to the Maturity Date, the Company exercised its right to redeem 1,000,000 of the Commitment Fee Shares for a nominal redemption price of $1.00. The issuance of the Commitment Fee Shares resulted in a debt discount of $ 268,250 - - On February 3, 2020, the Company, through its wholly-owned subsidiary, One World Pharma SAS, received an advance of 100,000,000 29,134 6 50,000,000 14,567 50,000,000 14,567 - 14,567 On December 16, 2020, the Company received an advance of $ 125,000 6 130,610 125,000 5,610 - 125,000 On October 28, 2020, the Company received an advance of $ 50,000 6 52,918 50,000 2,918 October 18, 2021 - 50,000 On September 14, 2020, the Company received an advance of $ 26,000 6 March 29, 2021 - 26,000 On May 4, 2020, the Company, through its wholly-owned subsidiary OWP Ventures, Inc., borrowed $ 119,274 1.00 May 4, 2022 Under the Payroll Protection Program, the Company was eligible for loan forgiveness up to the full amount of the PPP Note and any accrued interest. The forgiveness amount was equal to the amount that the Company spent during the 24-week period beginning May 4, 2020 on payroll costs, payment of rent on any leases in force prior to February 15, 2020 and payment on any utility for which service began before February 15, 2020. The maximum amount of loan forgiveness for non-payroll expenses was 40 121,372 119,274 2,098 February 11, 2022 119,274 119,274 Total notes payable 319,274 334,841 Less: current maturities 119,274 334,841 Notes payable, long-term potion $ 200,000 $ -
Schedule of Interest Expenses	The Company recognized interest expense for the year ended December 31, 2021 and 2020, respectively, as follows: Schedule of Interest Expenses December 31, December 31, 2021 2020 Interest on convertible notes $ 17,260 $ 21,516 Interest on notes payable 28,674 9,734 Amortization of debt discounts 42,247 - Amortization of stock-based debt discounts 414,409 - Interest on accounts payable 8,541 16,342 Total interest expense $ 511,131 $ 47,592

Convertible Preferred Stock (Ta

Convertible Preferred Stock (Tables)	12 Months Ended
	Dec. 31, 2021
Convertible Preferred Stock
Schedule to Purchase Shares of Preferred Stock	Schedule to Purchase Shares of Preferred Stock Date Shares Purchase Price Initial Closing Date 16,666 $ 249,990 February 22, 2021 16,667 250,005 March 8, 2021 16,667 250,005 March 22, 2021 16,667 250,005 April 5, 2021 16,666 249,990 April 19, 2021 16,667 250,005 May 17, 2021 33,334 500,010 June 14, 2021 33,333 499,995 July 12, 2021 33,333 499,995 Total 200,000 $ 3,000,000

Common Stock Options (Tables)

Common Stock Options (Tables)	12 Months Ended
	Dec. 31, 2021
Common Stock Options
Schedule of Option Exercise Price Range	The following is a summary of information about the Stock Options outstanding at December 31, 2021. Schedule of Option Exercise Price Range Shares Underlying Shares Underlying Options Outstanding Options Exercisable Weighted Shares Average Weighted Shares Weighted Underlying Remaining Average Underlying Average Range of Options Contractual Exercise Options Exercise Exercise Prices Outstanding Life Price Exercisable Price $ 0.13 0.56 10,742,000 8.63 $ 0.16 7,467,612 $ 0.17
Schedule of Option Activity	The following is a summary of activity of outstanding stock options: Schedule of Option Activity Weighted Average Number Exercise of Shares Prices Balance, December 31, 2019 766,669 $ 0.50 Options granted 9,875,000 0.51 Options exercised (9,366,669 ) (0.53 ) Balance, December 31, 2020 1,275,000 0.36 Options granted 9,592,000 0.14 Options exercised (125,000 ) (0.13 ) Balance, December 31, 2021 10,742,000 $ 0.16 Exercisable, December 31, 2021 7,467,612 $ 0.17

Common Stock Warrants (Tables)

Common Stock Warrants (Tables)	12 Months Ended
	Dec. 31, 2021
Common Stock Warrants
Schedule of Warrants to Purchase Common Stock Outstanding	The following is a summary of information about our warrants to purchase common stock outstanding at December 31, 2021. Schedule of Warrants to Purchase Common Stock Outstanding Shares Underlying Shares Underlying Warrants Outstanding Warrants Exercisable Weighted Shares Average Weighted Shares Weighted Range of Underlying Remaining Average Underlying Average Exercise Warrants Contractual Exercise Warrants Exercise Prices Outstanding Life Price Exercisable Price $ 0.25 0.50 11,011,650 3.31 $ 0.25 0.50 11,011,650 $ 0.25 0.50
Schedule of Fair value Assumption of Warrants	The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan: Schedule of Fair value Assumption of Warrants December 31, December 31, 2021 2020 Average risk-free interest rates 0.47 % 0.30 % Average expected life (in years) 3.00 5.00 Volatility 197 % 305 %
Schedule of Warrants Activity	The following is a summary of activity of outstanding common stock warrants: Schedule of Warrants Activity Weighted Average Number Exercise of Shares Prices Balance, December 31, 2019 - $ - Warrants granted 7,511,650 0.25 Balance, December 31, 2020 7,511,650 0.25 Warrants granted 3,500,000 0.39 Balance, December 31, 2021 11,011,650 $ 0.30 Exercisable, December 31, 2021 11,011,650 $ 0.30

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate	Schedule of Effective Income Tax Rate 2021 2020 December 31, 2021 2020 Federal statutory income tax rate 21 % 21 % State income taxes - % - % Change in valuation allowance (21 )% (21 )% Net effective income tax rate - -
Schedule of Deferred Tax Asset	The components of the Company’s deferred tax asset are as follows: Schedule of Deferred Tax Asset 2021 2020 December 31, 2021 2020 Deferred tax assets: Net operating loss carry forwards $ 1,535,000 $ 1,302,000 Net deferred tax assets before valuation allowance $ 1,535,000 $ 1,302,000 Less: Valuation allowance (1,535,000 ) (1,302,000 ) Net deferred tax assets $ - $ -

Schedule of Common Control and

Schedule of Common Control and Ownership Interest (Details)	12 Months Ended
	Dec. 31, 2021
Name of Entity	ONE WORLD PRODUCTS, INC.
State of Incorporation	NV
One World Products, Inc [Member]
Name of Entity	One World Products, Inc.	[1]
State of Incorporation	NV	[1]
Relationship	Parent	[1]
OWP Ventures Inc [Member]
Name of Entity	OWP Ventures, Inc.	[2]
State of Incorporation	DE	[2]
Relationship	Subsidiary	[2]
One World Pharma S.A.S. [Member]
Name of Entity	One World Pharma S.A.S.	[3]
State of Incorporation	F8	[3]
Relationship	Subsidiary	[3]
Colombian Hope, S.A.S. [Member]
Name of Entity	Colombian Hope, S.A.S.	[4]
State of Incorporation	F8	[4]
Relationship	Subsidiary	[4]
Agrobase, S.A.S. [Member]
Name of Entity	Agrobase, S.A.S.	[5]
State of Incorporation	F8	[5]
Relationship	Subsidiary	[5]
[1]	Holding company in the form of a corporation.
[2]	Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc.
[3]	Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá.
[4]	Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.
[5]	Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.

Schedule of Estimated Useful Li

Schedule of Estimated Useful Lives of Fixed Assets (Details)	12 Months Ended
	Dec. 31, 2021
Building [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	15 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	7 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	7 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives, description	Term of lease

Nature of Business and Signif_4

Nature of Business and Significant Accounting Policies (Details Narrative) - USD ($)	Feb. 21, 2019	Aug. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Sep. 24, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock exercise price					$ 0.1023
FDIC insured amount			$ 250,000
Cash uninsured amount			0
Deferred revenue			30,164
Deferred revenue cost of goods sold			19,470
Advertising and promotions expense			$ 137,915	$ 143,341
Merger Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Options to purchase common stock	825,000
Common stock exercise price	$ 0.50
Merger Agreement [Member] | OWP Ventures Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of stock issued	39,475,398
Options to purchase common stock	825,000
Common stock exercise price	$ 0.50
Proceeds from issuance convertible note	$ 300,000
Conversion price	$ 0.424
Number of shares cancelled	875,000
Deposits		$ 1,155,000
Construction cost		$ 1,400,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital	$ 879,410
Accumulated deficit	$ 19,916,888	$ 16,132,326

Schedule of Agreement to Purcha

Schedule of Agreement to Purchase Shares of Preferred Stock (Details) - USD ($)	Jul. 12, 2021	Jun. 14, 2021	May 17, 2021	Apr. 19, 2021	Apr. 05, 2021	Mar. 22, 2021	Mar. 08, 2021	Feb. 22, 2021	Feb. 07, 2021	Feb. 07, 2021	Jul. 12, 2021	Dec. 31, 2021	Dec. 31, 2020
Purchase price													$ 75,000
ISIAH International, LLC [Member] | Share Purchase Agreement [Member] | Series B Preferred Stock [Member]
Shares	33,333	33,333	33,334	16,667	16,666	16,667	16,667	16,667	200,000	16,666	200,000
Purchase price	$ 499,995	$ 499,995	$ 500,010	$ 250,005	$ 249,990	$ 250,005	$ 250,005	$ 250,005	$ 3,000,000	$ 249,990	$ 3,000,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 29, 2021	Oct. 18, 2021	Sep. 15, 2021	May 28, 2021	Mar. 29, 2021	Feb. 07, 2021	Jan. 02, 2021	Dec. 31, 2020	Jul. 10, 2020	Jun. 03, 2020	Jun. 03, 2020	May 31, 2020	Feb. 13, 2019	May 31, 2021	May 31, 2019	Nov. 23, 2018	Dec. 31, 2021	Dec. 31, 2020	Sep. 24, 2021	Jul. 26, 2021	Oct. 28, 2020
Issuance of common stock																			$ 75,000
Warrants term																						5 years
Warrants purchase	11,011,650																	11,011,650
Warrants exercise price	$ 0.10								$ 0.25									$ 0.10	$ 0.25			$ 0.25
Purchase price per share																					$ 0.13
Preferred stock, par value	0.001								$ 0.001									$ 0.001	$ 0.001
Common stock issued for services																		$ 133,755	$ 3,578,500
Stock option, call option, price per share																				$ 0.1023
Stock option, call option value																				$ 358,017
Share-based compensation																		$ 133,755	3,578,500
Series A Preferred Stock [Member]
Preferred stock, par value	10																	$ 10
Series B Preferred Stock [Member]
Preferred stock, par value	$ 15																	$ 15
Series B Preferred Stock [Member] | ISIAH International, LLC [Member] | Share Purchase Agreement [Member]
Issuance of common stock							$ 3,000,000
Number of shares issued, shares							200,000
Conversion of stock, shares issuable							20,000,000
Purchase price per share							$ 15
Preferred stock, par value							15
Conversion of stock conversion price per share							$ 0.15
Number of share purchase							200,000
Common Stock [Member]
Issuance of common stock																		$ 750	$ 500
Number of shares issued, shares																		750,000	500,000
Common stock issued for services, shares																		954,260	7,781,000
Common stock issued for services																		$ 955	$ 7,781
Isiah Thomas [Member]
Repayment of related party debt			$ 52,918	$ 130,610
Debt principal amount			50,000	125,000
Interest payable			$ 2,918	$ 5,610
Dr.Kenneth Perego II [Member]
Repayment of related party debt						$ 27,201
Debt principal amount						26,000
Interest payable						$ 1,201
Former Chief Executive Officer [Member]
Interest rate																	6.00%
Repayments of short term debt																	$ 514,141
Former Chief Executive Officer [Member] | Common Stock [Member]
Issuance of common stock																$ 200,000
Number of shares issued, shares																400,000
Dr Ken Perego [Member]
Common stock issued for services, shares													350,000
Common stock issued for services													$ 196,000
Number of options awarded during period, shares													350,000
Options exercise price, per share													$ 0.56
Options exercisable period													2 years
Stock option, volatility rate													302.00%
Stock option, call option, price per share													$ 0.5599
Stock option, call option value													$ 195,959
Share-based compensation																			102,056
Dr Ken Perego [Member] | Vesting Immediately [Member]
Number of options vested during period, shares													116,667
Dr Ken Perego [Member] | Vesting Quarterly Over Two Years [Member]
Number of options vested during period, shares													233,333
Dr Ken Perego [Member] | 2019 Stock Incentive Plan [Member]
Number of options awarded during period, shares								350,000
Options exercise price, per share								$ 0.13
Options exercisable period								10 years
Stock option, volatility rate								192.00%
Stock option, call option, price per share								$ 0.1170
Stock option, call option value								$ 40,943
Share-based compensation																		40,943
Dr Ken Perego [Member] | Series A Preferred Stock [Member]
Number of shares issued, shares										11,000
Proceeds from preferred stock										$ 110,000
Warrants term										5 years
Warrants purchase										50
Warrants exercise price										$ 0.25
Dr Ken Perego [Member] | Common Stock [Member]
Common stock issued for services, shares									750,000				350,000
Common stock issued for services									$ 90,000				$ 196,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member]
Number of options awarded during period, shares								5,500,000				5,500,000
Options exercise price, per share								$ 0.13			$ 0.55	$ 0.55
Options exercisable period								10 years				10 years
Stock option, volatility rate								192.00%				301.00%
Stock option, call option, price per share								$ 0.1174			$ 0.5499	$ 0.5499
Stock option, call option value								$ 645,624			$ 3,024,689	$ 3,024,689
Share-based compensation																		410,853	1,206,933
Unamortized expenses																		234,771
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Eleven Quarters [Member]
Number of options vested during period, shares								250,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Immediately [Member]
Number of options vested during period, shares								2,750,000				1,500,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly [Member]
Number of options vested during period, shares								2,750,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | 120 Days Following Issuance of Option [Member]
Number of options vested during period, shares												1,000,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly Over Three Years [Member]
Number of options vested during period, shares												3,000,000
Chief Executive Officer, Isiah L. Thomas III [Member] | Series B Preferred Stock [Member]
Number of shares issued, shares															3,334
Proceeds from preferred stock															$ 50,010
Purchase price per share															$ 15
Chief Executive Officer, Isiah L. Thomas III [Member] | Common Stock [Member]
Common stock issued for services, shares											500,000
Common stock issued for services											$ 275,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member]
Number of options awarded during period, shares					1,000,000
Options exercise price, per share					$ 0.1782
Options exercisable period					10 years
Stock option, volatility rate					183.00%
Stock option, call option, price per share					$ 0.1719
Stock option, call option value					$ 171,949
Share-based compensation																		171,949
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Vesting Immediately [Member]
Number of options vested during period, shares					500,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly [Member]
Number of options vested during period, shares					500,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Over Two Quarters [Member]
Number of options vested during period, shares					250,000
Vahe Gabriel [Member] | Common Stock [Member]
Common stock issued for services, shares	673,582
Common stock issued for services	$ 55,234
Bruce Raben [Member]
Number of options awarded during period, shares													350,000
Options exercise price, per share													$ 0.56
Options exercisable period													2 years
Stock option, volatility rate													302.00%
Stock option, call option, price per share													$ 0.5599
Stock option, call option value													$ 195,959
Share-based compensation																			102,056
Bruce Raben [Member] | Vesting Immediately [Member]
Number of options vested during period, shares													116,667
Bruce Raben [Member] | Vesting Quarterly Over Two Years [Member]
Number of options vested during period, shares													233,333
Bruce Raben [Member] | 2019 Stock Incentive Plan [Member]
Number of options awarded during period, shares								475,000
Options exercise price, per share								$ 0.13
Options exercisable period								10 years
Stock option, volatility rate								192.00%
Stock option, call option, price per share								$ 0.1170
Stock option, call option value								$ 55,565
Share-based compensation																		55,565
Bruce Raben [Member] | Common Stock [Member]
Common stock issued for services, shares									750,000
Common stock issued for services									$ 90,000
Former Chief Executive Officer, Craig Ellins [Member] | Common Stock [Member]
Common stock issued for services, shares											2,000,000
Common stock issued for services											$ 1,100,000
Two Consultants [Member]
Number of options awarded during period, shares													100,000
Options exercise price, per share													$ 0.56
Stock option, volatility rate													302.00%
Stock option, call option, price per share													$ 0.5599
Stock option, call option value													$ 55,994
Share-based compensation																		$ 12,100	25,760
Two Consultants [Member] | Vesting Immediately [Member]
Number of options vested during period, shares													33,333
Two Consultants [Member] | Vesting Quarterly Over Three Years [Member]
Number of options vested during period, shares													66,667
Six Consultants and Employees [Member]
Number of options awarded during period, shares													1,900,000
Options exercise price, per share													$ 0.56
Stock option, volatility rate													302.00%
Stock option, call option, price per share													$ 0.5599
Stock option, call option value													$ 1,063,879
Share-based compensation																			458,058
Six Consultants and Employees [Member] | Vesting Immediately [Member]
Number of options vested during period, shares													633,333
Six Consultants and Employees [Member] | Vesting Quarterly Over Three Years [Member]
Number of options vested during period, shares													1,266,667
Six Consultants and Employees [Member] | Vesting Quarterly Over Two Years [Member]
Number of options vested during period, shares													233,333
Unsecured Promissory Note [Member] | Kenneth Perego [Member]
Due to related parties, current		$ 200,000
Debt instrument maturity date		Jan. 1, 2024
Interest rate		8.00%
Promissory Note [Member] | Former Chief Executive Officer [Member]
Interest rate														6.00%
Debt principal amount														$ 307,141
Issuance of common stock																			$ 200,000
Number of shares issued, shares																			400,000
Promissory Notes [Member] | Minimum [Member]
Proceeds from private offering														5,000,000
Promissory Notes [Member] | Former Chief Executive Officer [Member]
Debt principal amount														307,141
Interest payable														$ 13,791

Schedule of Valuation of Financ

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Right-of-use-asset		$ 195,029
Convertible notes payable, debt discounts	412,673
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Cash	119,678	28,920
Right-of-use-asset
Total assets	119,678	28,920
Convertible notes payable, net of $412,673 of debt discounts
Convertible notes payable
Lease liabilities
Notes payable
Total liabilities
Total assets and liabilities	119,678	28,920
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Cash
Right-of-use-asset
Total assets
Convertible notes payable, net of $412,673 of debt discounts	337,327
Convertible notes payable	319,274
Lease liabilities
Notes payable		334,841
Total liabilities	(656,601)	(334,841)
Total assets and liabilities	(656,601)	(334,841)
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Cash
Right-of-use-asset		195,029
Total assets		195,029
Convertible notes payable, net of $412,673 of debt discounts
Convertible notes payable
Lease liabilities		201,525
Notes payable
Total liabilities		(201,525)
Total assets and liabilities		$ (6,496)

Major Customers and Accounts _2

Major Customers and Accounts Receivable (Details Narrative) - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2021
Revenue Benchmark [Member] | Four Customers [Member]
Product Information [Line Items]
Concentration risk, percentage	60.00%
Accounts Receivable [Member] | One Customers [Member]
Product Information [Line Items]
Concentration risk, percentage	75.00%

Schedule of Inventory (Details)

Schedule of Inventory (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 31,233	$ 27,514
Work in progress	81,182	181,272
Finished goods	108,246	104,673
Inventory gross	220,661	313,459
Less obsolescence	(22,066)	(46,307)
Total inventory	$ 198,595	$ 267,152

Schedule of Other Current Asset

Schedule of Other Current Assets (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
VAT tax receivable	$ 147,194	$ 99,199
Prepaid expenses	29,366	19,226
Deferred cost of goods sold	19,470
Other receivables	110,000	486
Total	$ 306,030	$ 118,911

Schedule of Security Deposits (

Schedule of Security Deposits (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Security deposits	$ 1,255,988	$ 65,114
Utility Deposits [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Security deposits	1,090	660
Refundable Deposit on Equipment Purchase [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Security deposits	50,000	50,000
Down Payment on Distillation Equipment [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Security deposits	1,155,000
Security Deposits on Leases Held in Colombia [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Security deposits	35,869	9,960
Security Deposit on Office Lease [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Security deposits	$ 14,029	$ 4,494

Schedule of Fixed Assets (Detai

Schedule of Fixed Assets (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 1,086,959	$ 782,059
Less: accumulated depreciation	(83,946)	(55,239)
Total	1,003,013	726,820
Land [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	138,248	138,248
Building [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	473,971	41,665
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	56,502	44,027
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	34,409	27,914
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	383,829	185,169
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross		$ 345,036

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	Nov. 30, 2021	Jul. 27, 2021	Jul. 01, 2021	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Proceeds from disposal of fixed assets	$ 0	$ 5,125	$ 0	$ 5,125
Loss on disposal of fixed assets	$ 53,925	$ 2,064	$ 15,498	(71,487)
Depreciation, Depletion and Amortization				$ 40,321	$ 33,610

Schedule of Accrued Expenses (D

Schedule of Accrued Expenses (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Accrued payroll	$ 261,044	$ 266,230
Accrued withholding taxes and employee benefits	9,162	18,889
Accrued ICA fees and contributions	129,856	200,335
Accrued interest	57,700	65,081
Accrued expenses	$ 457,762	$ 550,535

Deferred Revenues (Details Narr

Deferred Revenues (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Deferred Revenues
Contract with customer, liability, current	$ 30,164
Contract with customer, asset, after allowance for credit loss, current	19,470
Deferred revenue gross	$ 10,964

Schedule of Components of Lease

Schedule of Components of Lease Expense (Details)	12 Months Ended
	Dec. 31, 2021USD ($)
Leases
Amortization of assets	$ 87,276
Interest on lease liabilities	3,035
Total lease cost	$ 90,311

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Related to Leases (Details)	12 Months Ended
	Dec. 31, 2021USD ($)
Leases
Operating cash flows used for operating leases	$ 201,525

Schedule of Convertible Note Pa

Schedule of Convertible Note Payable (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Short-term Debt [Line Items]
Notes Payable	$ 319,274	$ 334,841
Notes payable, net of discounts	119,274	334,841
Convertible Debt [Member]
Short-term Debt [Line Items]
Notes Payable	750,000
Debt instrument, unamortized discount	412,673
Notes payable, net of discounts	337,327
Convertible Debt [Member] | Promissory Note [Member]
Short-term Debt [Line Items]
Notes Payable	$ 750,000

Schedule of Convertible Note _2

Schedule of Convertible Note Payable (Details) (Parenthetical)	Sep. 24, 2021USD ($)Integer$ / sharesshares	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / shares	Oct. 28, 2020$ / shares
Short-term Debt [Line Items]
Warrants term				5 years
Warrants purchase | shares		11,011,650
Warrants exercise price | $ / shares		$ 0.10	$ 0.25	$ 0.25
Debt discount		$ 456,656
Number of stock issued for commitment fee, shares		133,755	$ 3,578,500
AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Short-term Debt [Line Items]
Debt instrument, face value	$ 705,000
Warrants term	3 years
Warrants purchase | shares	2,000,000
Warrants exercise price | $ / shares	$ 0.50
Debt discount		268,250
Number of stock issued for commitment fee, shares		$ 2,000,000
Promissory Note [Member] | AJB Capital Investments LLC [Member]
Short-term Debt [Line Items]
Debt instrument, face value	$ 750,000
Warrants term	3 years
Warrants purchase | shares	1,500,000
Warrants exercise price | $ / shares	$ 0.25
Debt discount	$ 150,062
Debt instrument maturity date	Sep. 24, 2022
Debt interest rate	8.00%
Trading days | Integer	20
Number of stock issued for commitment fee, shares	$ 250,000
Number of stock issued for commitment fee | shares	1,250,000
Promissory Note [Member] | AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Short-term Debt [Line Items]
Debt instrument, face value	$ 705,000
Warrants term	3 years
Warrants purchase | shares	2,000,000
Warrants exercise price | $ / shares	$ 0.50
Debt discount	$ 678,750
Original issue discount	45,000
Legal fees	15,000
Brokerage fees	$ 11,250

Schedule of Convertible Debt Di

Schedule of Convertible Debt Discounts (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Fair value of 3,250,000 commitment shares of common stock	$ 418,312
Fair value of warrants to purchase 3,500,000 shares of common stock	358,017
Original issue discounts	53,700
Legal and brokerage fees	39,300
Total debt discounts	869,329
Amortization of debt discounts	456,656
Unamortized debt discounts	$ 412,673

Schedule of Convertible Debt _2

Schedule of Convertible Debt Discounts (Details) (Parenthetical) - shares	Dec. 31, 2021	Dec. 31, 2020	Oct. 28, 2020
Debt Disclosure [Abstract]
Fair value commitment shares	3,250,000	3,250,000
Fair value warrants to purchase	3,500,000	3,500,000	7,511,650

Convertible Note Payable (Detai

Convertible Note Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Short-term Debt [Line Items]
Debt discount	$ 869,329
Finance expense	$ 456,656
Common stock percentage	4.99%
Interest expense	$ 17,260	21,516
Interest expense related to the debt discount	456,656
Convertible Debt [Member]
Short-term Debt [Line Items]
Interest expense	$ 36,243	$ 21,516

Schedule of Notes Payable (Deta

Schedule of Notes Payable (Details) - USD ($)	Jan. 20, 2021	Dec. 31, 2021	Dec. 31, 2020
Short-term Debt [Line Items]
Total notes payable		$ 319,274	$ 334,841
Less: current maturities		119,274	334,841
Notes payable, long-term potion		200,000
Unsecured Promissory Note One [Member]
Short-term Debt [Line Items]
Total notes payable		200,000
Unsecured Promissory Note Two [Member]
Short-term Debt [Line Items]
Total notes payable
Unsecured Promissory Note Two [Member] | AJB Capital Investments LLC [Member]
Short-term Debt [Line Items]
Proceeds from Issuance of Debt	$ 268,250
Unsecured Promissory Note Three [Member]
Short-term Debt [Line Items]
Total notes payable			14,567
Unsecured Promissory Note Four [Member]
Short-term Debt [Line Items]
Total notes payable			125,000
Unsecured Promissory Note Five [Member]
Short-term Debt [Line Items]
Total notes payable			50,000
Unsecured Promissory Note Six [Member]
Short-term Debt [Line Items]
Total notes payable			26,000
Unsecured Promissory Note Seven [Member]
Short-term Debt [Line Items]
Total notes payable		$ 119,274	$ 119,274

Schedule of Notes Payable (De_2

Schedule of Notes Payable (Details) (Parenthetical)

Dec. 29, 2021USD ($)

Jan. 20, 2021USD ($)shares

Dec. 16, 2020USD ($)

Oct. 28, 2020USD ($)

Sep. 14, 2020USD ($)

Jun. 03, 2020USD ($)shares

May 04, 2020USD ($)

Dec. 31, 2021USD ($)

Dec. 31, 2021COP ($)

Dec. 31, 2020USD ($)

Dec. 31, 2020COP ($)

Mar. 29, 2021USD ($)

Feb. 03, 2020USD ($)

Feb. 03, 2020COP ($)

Short-term Debt [Line Items]

Proceeds from notes payable

$ 1,147,000

$ 476,841

Stock Issued During Period, Value, Issued for Services

133,755

3,578,500

Repayments of notes payable

505,567

272,000

OWP Ventures Inc [Member]

Short-term Debt [Line Items]

Advance, repayment date

Feb. 11, 2022

Dr.Kenneth Perego II [Member]

Short-term Debt [Line Items]

Debt instrument, face value

$ 26,000

Chief Executive Officer, Isaih L. Thomas [Member]

Short-term Debt [Line Items]

Stock Issued During Period, Value, Issued for Services

$ 275,000

Stock Issued During Period, Shares, Issued for Services | shares

500,000

Unsecured Promissory Note One [Member] | Dr.Kenneth Perego II [Member]

Short-term Debt [Line Items]

Debt instrument, face value

$ 200,000

Advance, repayment date

Jan. 1, 2024

Debt interest rate

8.00%

Unsecured Promissory Note Two [Member] | AJB Capital Investments LLC [Member]

Short-term Debt [Line Items]

Debt instrument, face value

$ 290,000

Advance, repayment date

Oct. 20, 2021

Debt interest rate

10.00%

Proceeds from notes payable

$ 281,300

Proceeds from debt discount

268,250

Original issue discount

8,700

Legal fees

7,250

Brokerage fees

5,800

Stock Issued During Period, Value, Issued for Services

$ 200,000

Stock Issued During Period, Shares, Issued for Services | shares

2,000,000

Debt Instrument, Description

As the Company repaid the First AJB Note prior to the Maturity Date, the Company exercised its right to redeem 1,000,000 of the Commitment Fee Shares for a nominal redemption price of $1.00. The issuance of the Commitment Fee Shares resulted in a debt discount of $

Unsecured Promissory Note Three [Member] | One World Pharma S.A.S. [Member]

Short-term Debt [Line Items]

Debt interest rate

6.00%

6.00%

Advance from affiliates

$ 29,134

$ 100,000,000

Repayments of notes payable

$ 14,567

$ 50,000,000

$ 14,567

$ 50,000,000

Unsecured Promissory Note Four [Member] | Chief Executive Officer, Isaih L. Thomas [Member]

Short-term Debt [Line Items]

Debt interest rate

6.00%

Advance from affiliates

$ 125,000

Debt

130,610

Principal payment

125,000

Interest rate

$ 5,610

Unsecured Promissory Note Five [Member] | Chief Executive Officer, Isaih L. Thomas [Member]

Short-term Debt [Line Items]

Debt interest rate

6.00%

Advance from affiliates

$ 50,000

Debt

52,918

Principal payment

50,000

Interest rate

$ 2,918

Unsecured Promissory Note Due on Demand Five [Member] | Kenneth Perego [Member]

Short-term Debt [Line Items]

Advance, repayment date

Oct. 18, 2021

Unsecured Promissory Note Six [Member] | Kenneth Perego [Member]

Short-term Debt [Line Items]

Advance, repayment date

Mar. 29, 2021

Debt interest rate

6.00%

Advance from affiliates

$ 26,000

Unsecured Promissory Note Seven [Member] | OWP Ventures Inc [Member]

Short-term Debt [Line Items]

Advance, repayment date

May 4, 2022

Debt

$ 121,372

Principal payment

119,274

Interest rate

$ 2,098

Loan forgiveness, percentage

40.00%

Unsecured Promissory Note Seven [Member] | Lenders [Member] | OWP Ventures Inc [Member]

Short-term Debt [Line Items]

Debt interest rate

1.00%

Advance from affiliates

$ 119,274

Schedule of Interest Expenses (

Schedule of Interest Expenses (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Notes Payable
Interest on convertible notes	$ 17,260	$ 21,516
Interest on notes payable	28,674	9,734
Amortization of debt discounts	42,247
Amortization of stock-based debt discounts	414,409
Interest on accounts payable	8,541	16,342
Total interest expense	$ 511,131	$ 47,592

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Short-term Debt [Line Items]
Interest expense	$ 511,131	$ 47,592
Officers and Directors [Member]
Short-term Debt [Line Items]
Interest payable	9,729
Notes Payable [Member]
Short-term Debt [Line Items]
Interest expense	$ 28,674	$ 9,734

Schedule to Purchase Shares of

Schedule to Purchase Shares of Preferred Stock (Details) - USD ($)	Jul. 12, 2021	Jun. 14, 2021	May 17, 2021	Apr. 19, 2021	Apr. 05, 2021	Mar. 22, 2021	Mar. 08, 2021	Feb. 22, 2021	Feb. 07, 2021	Feb. 07, 2021	Jul. 12, 2021	Dec. 31, 2021	Dec. 31, 2020
Purchase price													$ 75,000
ISIAH International, LLC [Member] | Share Purchase Agreement [Member] | Series B Preferred Stock [Member]
Shares	33,333	33,333	33,334	16,667	16,666	16,667	16,667	16,667	200,000	16,666	200,000
Purchase price	$ 499,995	$ 499,995	$ 500,010	$ 250,005	$ 249,990	$ 250,005	$ 250,005	$ 250,005	$ 3,000,000	$ 249,990	$ 3,000,000

Convertible Preferred Stock (De

Convertible Preferred Stock (Details Narrative) - USD ($)	Nov. 15, 2021	Jul. 12, 2021	Jun. 14, 2021	May 17, 2021	Apr. 19, 2021	Apr. 06, 2021	Apr. 05, 2021	Mar. 24, 2021	Mar. 22, 2021	Mar. 08, 2021	Feb. 22, 2021	Feb. 07, 2021	Feb. 07, 2021	Jan. 26, 2021	Jan. 12, 2021	Apr. 22, 2021	Jul. 12, 2021	Oct. 28, 2020	Dec. 31, 2021	Dec. 31, 2020	Jul. 26, 2021
Preferred stock, shares authorized																			9,500,000	9,500,000
Preferred stock, par value																			$ 0.001	$ 0.001
Number of stock sold, shares																		150,233
Warrant term																		5 years
Number of warrants to purchase common stock																		7,511,650	3,500,000	3,500,000
Exercise price of warrants																		$ 0.25	$ 0.10	$ 0.25
Preferred stock dividend recognized																			$ 61,684	$ 37,236
Issuance of common stock																				$ 75,000
Purchase price per share																					$ 0.13
Series A Convertible Preferred Stock [Member]
Preferred stock, shares authorized																			10,000,000
Preferred stock, par value																			$ 0.001
Preferred stock shares designated																			500,000
Conversion of preferred stock into common stock, description																			The shares of Series A Preferred Stock and Series B Preferred Stock are each currently convertible into one hundred (100) shares of the Company’s common stock
Dividend rate percentage																			6.00%
Series A convertible preferred stock, issued																			65,233	150,233
Series A convertible preferred stock, outstanding																			65,233	150,233
Purchase price per share																			$ 0.60	$ 0.60
Series B Convertible Preferred Stock [Member]
Preferred stock shares designated																			300,000
Series A convertible preferred stock, issued																			238,501	0
Series A convertible preferred stock, outstanding																			238,501	0
Series A Preferred Stock [Member]
Preferred stock, shares authorized																			10,000,000
Preferred stock, par value																			$ 10
Preferred stock shares designated																			500,000
Dividend rate percentage																			6.00%
Number of stock sold, shares																		150,233	0
Conversion of stock, shares converted	30,000					30,000		10,000						5,000	10,000
Dividends, Preferred Stock, Cash																			$ 98,920
Series A Preferred Stock [Member] | Preferred Stock Sales [Member]
Number of stock sold, shares																		150,233
Proceeds from sale of stock																		$ 1,502,330
Warrant term																		5 years
Number of warrants to purchase common stock																		7,511,650
Exercise price of warrants																		$ 0.25
Series B Preferred Stock [Member]
Preferred stock, par value																			$ 15
Preferred stock shares designated																			300,000
Series B Preferred Stock [Member] | Seven Accredited Investors [Member]
Number of shares issued, shares																35,167
Issuance of common stock																$ 527,520
Purchase price per share																$ 15
Series B Preferred Stock [Member] | Chief Executive Officer, Isiah L. Thomas III [Member]
Number of shares issued, shares																3,334
Issuance of common stock																$ 50,010
Purchase price per share																$ 15
Series B Preferred Stock [Member] | Share Purchase Agreement [Member] | ISIAH International, LLC [Member]
Preferred stock, par value												$ 15	$ 15
Number of shares issued, shares		33,333	33,333	33,334	16,667		16,666		16,667	16,667	16,667	200,000	16,666				200,000
Conversion of stock, shares issuable												20,000,000
Issuance of common stock		$ 499,995	$ 499,995	$ 500,010	$ 250,005		$ 249,990		$ 250,005	$ 250,005	$ 250,005	$ 3,000,000	$ 249,990				$ 3,000,000
Purchase price per share												$ 15	$ 15
Conversion of stock conversion price per share												$ 0.15	$ 0.15
Share purchase												200,000
Common Stock [Member]
Conversion of stock, shares issued	3,000,000					3,000,000		1,000,000						500,000	1,000,000

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 01, 2021	Dec. 01, 2021	Jul. 26, 2021	Jun. 02, 2021	May 25, 2021	May 12, 2021	Dec. 31, 2020	Nov. 27, 2020	Sep. 21, 2020	Jul. 10, 2020	Jul. 02, 2020	Jun. 03, 2020	May 31, 2020	Jan. 06, 2020	Aug. 20, 2019	Oct. 28, 2020	Dec. 31, 2021	Dec. 31, 2020	Oct. 15, 2021
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	9,500,000							9,500,000										9,500,000	9,500,000
Common stock, shares authorized	300,000,000							300,000,000										300,000,000	300,000,000
Common stock, par value	$ 0.001							$ 0.001										$ 0.001	$ 0.001
Common stock, shares issued	65,599,565							53,085,305										65,599,565	53,085,305
Common stock, shares outstanding	65,599,565							53,085,305										65,599,565	53,085,305
Shares issued for options exercised, shares				60,000
Options outstanding				125,000
Shares issued price per share				$ 0.13
Number of stock sold, shares																	150,233
Subscriptions payable	$ 21,725							$ 75,000										$ 21,725	$ 75,000
Common stock issued for services																		133,755	3,578,500
Amortization of Debt Discount (Premium)																		456,656
Common stock sold for cash																			75,000
Four Employees and Consultants [Member]
Class of Stock [Line Items]
Common stock issued for services												$ 332,500
Common stock issued for services, shares												875,000
Consultant [Member]
Class of Stock [Line Items]
Common stock issued for services													$ 120,000
Common stock issued for services, shares													200,000
Ten Employees and Consultants [Member]
Class of Stock [Line Items]
Common stock issued for services														$ 1,318,000
Common stock issued for services, shares														2,006,000
Dr Ken Perego [Member]
Class of Stock [Line Items]
Common stock issued for services														$ 196,000
Common stock issued for services, shares														350,000
Chief Executive Officer, Isaih L. Thomas [Member]
Class of Stock [Line Items]
Common stock issued for services													$ 275,000
Common stock issued for services, shares													500,000
Chief Executive Officer, Craig Ellins [Member]
Class of Stock [Line Items]
Common stock issued for services													$ 1,100,000
Common stock issued for services, shares													2,000,000
Two Individuals [Member]
Class of Stock [Line Items]
Common stock issued for services						$ 8,500
Common stock issued for services, shares						50,000
COR Prominence LLC [Member]
Class of Stock [Line Items]
Common stock issued for services			$ 21,725		$ 18,758
Common stock issued for services, shares		262,066			112,528
Consultants [Member]
Class of Stock [Line Items]
Common stock issued for services										$ 45,000
Common stock issued for services, shares										250,000
Purchase Agreement [Member] | Second A B J Note [Member]
Class of Stock [Line Items]
Common stock issued for services																		1,250,000
Amortization of Debt Discount (Premium)																		150,062
Finance expense																		43,168
Purchase Agreement [Member] | AJB Capital Investments LLC [Member]
Class of Stock [Line Items]
Debt Instrument, Fee Amount	200,000																	200,000
Common stock issued for services																		2,000,000
Amortization of Debt Discount (Premium)																		268,250
Finance expense																		$ 268,250
Settlement Agreement [Member] | COR Prominence LLC [Member]
Class of Stock [Line Items]
Services consideration, description																the Company engaged COR Prominence, LLC (“COR”) to provide investor relation services to the Company, in consideration for the payment of $7,500 per month in cash, and $5,000 per month with shares of common stock valued at 125% of the closing price of the common stock of the Company on the date of issuance
Cash payments																$ 7,500
Shares payments																$ 5,000
Common stock sold for cash, shares							118,150
Common stock sold for cash							$ 29,538
Common Stock [Member]
Class of Stock [Line Items]
Shares issued for options exercised, shares																		60,000
Number of stock sold, shares									750,000
Sale of stock price per share									$ 0.10
Proceeds from sale of stock									$ 75,000
Common stock issued for services																		$ 955	$ 7,781
Common stock issued for services, shares																		954,260	7,781,000
Common stock sold for cash, shares																		750,000	500,000
Common stock sold for cash																		$ 750	$ 500
Common Stock [Member] | Vahe Gabriel [Member]
Class of Stock [Line Items]
Common stock issued for services	$ 55,234
Common stock issued for services, shares	673,582
Common Stock [Member] | Dr Ken Perego [Member]
Class of Stock [Line Items]
Common stock issued for services								$ 90,000						$ 196,000
Common stock issued for services, shares								750,000						350,000
Common Stock [Member] | Bruce Raben [Member]
Class of Stock [Line Items]
Common stock issued for services								$ 90,000
Common stock issued for services, shares								750,000
Common Stock [Member] | Consultant [Member]
Class of Stock [Line Items]
Common stock issued for services								$ 12,000
Common stock issued for services, shares								100,000
Common Stock [Member] | Subscription Payable [Member]
Class of Stock [Line Items]
Number of stock sold, shares															500,000
Sale of stock price per share															$ 0.50					$ 1
Subscriptions payable															$ 25,000
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	10,000,000																	10,000,000
Temporary Equity, Par or Stated Value Per Share	$ 0.001																	$ 0.001
Preferred stock shares designated	500,000																	500,000
Number of stock sold, shares																	150,233	0
Series A Preferred Stock [Member] | Dr Ken Perego [Member]
Class of Stock [Line Items]
Common stock sold for cash, shares											11,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock shares designated	300,000																	300,000

Schedule of Option Exercise Pri

Schedule of Option Exercise Price Range (Details)	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Common Stock Options
Shares Underlying Options Outstanding, Exercise Price Range, Lower Range Limit	$ 0.13
Shares Underlying Options Outstanding, Exercise Price Range, Upper Range Limit	$ 0.56
Shares Underlying Options Outstanding, shares | shares	10,742,000
Shares Underlying Options Outstanding, Weighted Average Remaining Life (Years)	8 years 7 months 17 days
Shares Underlying Options Outstanding, Weighted Average Exercise Price	$ 0.16
Shares Underlying Options Exercisable, Number of shares, shares | shares	7,467,612
Shares Underlying Options Exercisable, Weighted Average Exercise Price	$ 0.17

Schedule of Option Activity (De

Schedule of Option Activity (Details) - $ / shares	Jul. 26, 2021	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Options exercised	(60,000)
Number of Shares, Ending	125,000
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Beginning		1,275,000	766,669
Weighted Average Exercise Prices, Beginning		$ 0.36	$ 0.50
Number of Shares, Options granted		9,592,000	9,875,000
Weighted Average Exercise Prices, Options granted		$ 0.14	$ 0.51
Number of Shares, Options exercised		(125,000)	(9,366,669)
Weighted Average Exercise Prices, Options exercised		$ (0.13)	$ (0.53)
Number of Shares, Ending		10,742,000	1,275,000
Weighted Average Exercise Prices, Ending		$ 0.16	$ 0.36
Number of Shares, Exercisable Ending		7,467,612
Weighted Average Exercise Prices, Exercisable Ending		$ 0.17

Common Stock Options (Details N

Common Stock Options (Details Narrative) - USD ($)	Jul. 26, 2021	May 28, 2021	May 25, 2021	Jan. 02, 2021	Dec. 31, 2020	Jul. 02, 2020	Jun. 03, 2020	May 31, 2020	Feb. 12, 2020	Dec. 31, 2021	Dec. 31, 2020	Sep. 24, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option, call option, price per share												$ 0.1023
Stock option, call option value												$ 358,017
Unamortized debt issuance expense										$ 255,026
Stock based compensation expense										133,755	$ 3,578,500
Shares issued for options exercised, shares	60,000
Options outstanding	125,000
Shares issued price per share	$ 0.13
Board of Directors [Member] | 2019 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock sold for cash, shares									10,000,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares		1,000,000
Options exercise price, per share		$ 0.1782
Options exercisable period		10 years
Stock option, volatility rate		183.00%
Stock option, call option, price per share		$ 0.1719
Stock option, call option value		$ 171,949
Unamortized debt issuance expense										171,949
Stock based compensation expense										171,949
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares		500,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Vesting Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares		500,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Vesting Two Quarters [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares		250,000
Three Advisory Board Members [Member] | 2019 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares			425,000
Options exercise price, per share			$ 0.17
Options exercisable period			10 years
Stock option, volatility rate			183.00%
Stock option, call option, price per share			$ 0.1653
Stock option, call option value			$ 70,269
Unamortized debt issuance expense										49,776
Stock based compensation expense										20,493
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares				5,500,000			5,500,000
Options exercise price, per share				$ 0.13			$ 0.55
Options exercisable period				10 years			10 years
Stock option, volatility rate				192.00%			301.00%
Stock option, call option, price per share				$ 0.1174			$ 0.5499
Stock option, call option value				$ 645,624			$ 3,024,689
Unamortized debt issuance expense										234,771
Stock based compensation expense										410,853	1,206,933
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares				2,750,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares				2,750,000			1,500,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Eleven Quarters [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares				250,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | 120 Days Following Issuance of Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares							1,000,000
Chief Executive Officer, Isiah L. Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly Over Three Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares							3,000,000
Dr Ken Perego [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares								350,000
Options exercise price, per share								$ 0.56
Options exercisable period								2 years
Stock option, volatility rate								302.00%
Stock option, call option, price per share								$ 0.5599
Stock option, call option value								$ 195,959
Stock based compensation expense											102,056
Dr Ken Perego [Member] | Vesting Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares								116,667
Dr Ken Perego [Member] | Vesting Quarterly Over Two Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares								233,333
Dr Ken Perego [Member] | 2019 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares				350,000
Options exercise price, per share				$ 0.13
Options exercisable period				10 years
Stock option, volatility rate				192.00%
Stock option, call option, price per share				$ 0.1170
Stock option, call option value				$ 40,943
Unamortized debt issuance expense										40,943
Stock based compensation expense										40,943
Bruce Raben [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares								350,000
Options exercise price, per share								$ 0.56
Options exercisable period								2 years
Stock option, volatility rate								302.00%
Stock option, call option, price per share								$ 0.5599
Stock option, call option value								$ 195,959
Stock based compensation expense											$ 102,056
Bruce Raben [Member] | Vesting Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares								116,667
Bruce Raben [Member] | Vesting Quarterly Over Two Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares								233,333
Bruce Raben [Member] | 2019 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares				475,000
Options exercise price, per share				$ 0.13
Options exercisable period				10 years
Stock option, volatility rate				192.00%
Stock option, call option, price per share				$ 0.1170
Stock option, call option value				$ 55,565
Unamortized debt issuance expense										55,565
Stock based compensation expense										55,565
Seven Consultants and Employees [Member] | 2019 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares				1,842,000
Options exercise price, per share				$ 0.13
Options exercisable period				10 years
Stock option, volatility rate				192.00%
Stock option, call option, price per share				$ 0.1170
Stock option, call option value				$ 215,475
Unamortized debt issuance expense										215,475
Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares					250,000	125,000
Options exercise price, per share					$ 0.13	$ 0.38					$ 0.13
Options exercisable period						10 years
Stock option, volatility rate					192.00%	303.00%
Stock option, call option, price per share					$ 0.1170	$ 0.3798					$ 0.1170
Stock option, call option value					$ 29,245	$ 47,476					$ 29,245
Unamortized debt issuance expense										29,245
Stock based compensation expense											$ 47,476
Consultant Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares					125,000	1,000,000
Options exercise price, per share					$ 0.13	$ 0.38					$ 0.13
Options exercisable period						10 years
Stock option, volatility rate					192.00%	303.00%
Stock option, call option, price per share					$ 0.1170	$ 0.38					$ 0.1170
Stock option, call option value					$ 14,622	$ 379,958					$ 14,622
Unamortized debt issuance expense										14,622
Stock based compensation expense											$ 63,326
Consultant Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares					50,000
Options exercise price, per share					$ 0.13						$ 0.13
Stock option, volatility rate					192.00%
Stock option, call option, price per share					$ 0.1170						$ 0.1170
Stock option, call option value					$ 5,849						$ 5,849
Unamortized debt issuance expense										5,849
Consultant for Advisory Board Services [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares						125,000
Options exercise price, per share						$ 0.38
Options exercisable period						10 years
Stock option, volatility rate						303.00%
Stock option, call option, price per share						$ 0.3799
Stock option, call option value						$ 47,482
Stock based compensation expense										23,742	23,742
Six Consultants and Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares								1,900,000
Options exercise price, per share								$ 0.56
Stock option, volatility rate								302.00%
Stock option, call option, price per share								$ 0.5599
Stock option, call option value								$ 1,063,879
Stock based compensation expense											458,058
Six Consultants and Employees [Member] | Vesting Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares								633,333
Six Consultants and Employees [Member] | Vesting Quarterly Over Three Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares								1,266,667
Two Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options awarded during period, shares								100,000
Options exercise price, per share								$ 0.56
Stock option, volatility rate								302.00%
Stock option, call option, price per share								$ 0.5599
Stock option, call option value								$ 55,994
Unamortized debt issuance expense										18,134
Stock based compensation expense										$ 12,100	$ 25,760
Two Consultants [Member] | Vesting Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares								33,333
Two Consultants [Member] | Vesting Quarterly Over Three Years [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options vested during period, shares								66,667

Schedule of Warrants to Purchas

Schedule of Warrants to Purchase Common Stock Outstanding (Details)	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Shares Underlying Warrants Outstanding, Range of Exercise Prices	$ 0.13
Shares Underlying Warrants Outstanding | shares	10,742,000
Shares Underlying Warrants Outstanding, Weighted Average Remaining Contractual Life	8 years 7 months 17 days
Shares Underlying Warrants Outstanding, Weighted Average Exercise Price	$ 0.16
Shares Underlying Warrants Exercisable | shares	7,467,612
Shares Underlying Warrants Exercisable, Weighted Average Exercise Price	$ 0.17
Warrant [Member]
Shares Underlying Warrants Outstanding | shares	11,011,650
Shares Underlying Warrants Outstanding, Weighted Average Remaining Contractual Life	3 years 3 months 21 days
Shares Underlying Warrants Exercisable | shares	11,011,650
Warrant [Member] | Minimum [Member]
Shares Underlying Warrants Outstanding, Range of Exercise Prices	$ 0.25
Shares Underlying Warrants Outstanding, Weighted Average Exercise Price	0.25
Shares Underlying Warrants Exercisable, Weighted Average Exercise Price	0.25
Warrant [Member] | Maximum [Member]
Shares Underlying Warrants Outstanding, Range of Exercise Prices	0.50
Shares Underlying Warrants Outstanding, Weighted Average Exercise Price	0.50
Shares Underlying Warrants Exercisable, Weighted Average Exercise Price	$ 0.50

Schedule of Fair value Assumpti

Schedule of Fair value Assumption of Warrants (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Average risk-free interest rates	0.47%	0.30%
Average expected life (in years)	3 years	5 years
Volatility	197.00%	305.00%

Schedule of Warrants Activity (

Schedule of Warrants Activity (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Number of Shares, Outstanding	7,511,650
Weighted Average Exercise Price, Outstanding	$ 0.25
Number of Shares, Warrants granted	3,500,000	7,511,650
Weighted Average Exercise Price, Warrants granted	$ 0.39	$ 0.25
Number of Shares, Outstanding	11,011,650	7,511,650
Weighted Average Exercise Price, Outstanding	$ 0.30	$ 0.25
Number of Shares, Exercisable	11,011,650
Weighted Average Exercise Price, Exercisable	$ 0.30

Common Stock Warrants (Details

Common Stock Warrants (Details Narrative)	6 Months Ended	12 Months Ended
	Oct. 28, 2020USD ($)$ / sharesshares	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020$ / sharesshares	Sep. 24, 2021USD ($)$ / sharesshares
Warrants purchase | shares		11,011,650
Warrant term	5 years
Exercise price of warrants | $ / shares	$ 0.25	$ 0.10	$ 0.25
Common stock exercise price | $ / shares				$ 0.1023
Stock option, call option value				$ 358,017
Stock-based compensation		$ 102,991
Unamortized debt issuance expense		$ 255,026
Proceeds from equity securities	$ 1,502,330
Sale of stock | shares	150,233
Number of warrants to purchase common stock | shares	7,511,650	3,500,000	3,500,000
Warrants outstanding value		$ 2,164,995
Measurement Input, Price Volatility [Member]
Warrants outstanding measurement input		3.05
Measurement Input, Share Price [Member]
Warrants outstanding measurement input		0.002882
Series A Preferred Stock [Member]
Sale of stock | shares	150,233	0
Warrant [Member]
Volatility rate		197.00%	305.00%
AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Warrants purchase | shares				2,000,000
Debt instrument, face value				$ 705,000
Warrant term				3 years
Exercise price of warrants | $ / shares				$ 0.50
Promissory Note [Member] | AJB Capital Investments LLC [Member]
Warrants purchase | shares				1,500,000
Debt instrument, face value				$ 750,000
Warrant term				3 years
Exercise price of warrants | $ / shares				$ 0.25
Promissory Note [Member] | AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Warrants purchase | shares				2,000,000
Debt instrument, face value				$ 705,000
Warrant term				3 years
Exercise price of warrants | $ / shares				$ 0.50

Schedule of Effective Income Ta

Schedule of Effective Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Federal statutory income tax rate	21.00%	21.00%
State income taxes
Change in valuation allowance	(21.00%)	(21.00%)
Net effective income tax rate

Schedule of Deferred Tax Asset

Schedule of Deferred Tax Asset (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 1,535,000	$ 1,302,000
Net deferred tax assets before valuation allowance	1,535,000	1,302,000
Less: Valuation allowance	(1,535,000)	(1,302,000)
Net deferred tax assets

Income Tax (Details Narrative)

Income Tax (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Federal net operating losses	$ 7,309,000
Net operating loss carry forwards expiration	The net operating loss carry forwards, if not utilized, will begin to expire in 2025.
Effective tax rate	21.00%	21.00%

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Mar. 29, 2022shares	Mar. 01, 2022USD ($)	Feb. 15, 2022USD ($)	Jan. 01, 2022USD ($)ft²	Jan. 01, 2022COP ($)ft²	May 04, 2020	Oct. 28, 2020shares
Subsequent Event [Line Items]
Sale of stock, shares | shares							150,233
OWP Ventures Inc [Member]
Subsequent Event [Line Items]
Debt maturity date						Feb. 11, 2022
Subsequent Event [Member]
Subsequent Event [Line Items]
Sale of stock, shares | shares	262,066
Lease commitment term				10 years	10 years
Area of land | ft²				38,750	38,750
Monthly lease payment				$ 15,290	$ 57,339,000
Lease commitment, description				commence January 1, 2022 for a ten-year term that carries automatic options to extend for successive terms of five (5) years, as long as neither party has given notice of termination at least six (6) months in advance.	commence January 1, 2022 for a ten-year term that carries automatic options to extend for successive terms of five (5) years, as long as neither party has given notice of termination at least six (6) months in advance.
Subsequent Event [Member] | OWP Ventures Inc [Member]
Subsequent Event [Line Items]
Debt instrument, face value | $			$ 200,000
Debt maturity date			Jan. 1, 2024
Debt interest rate, percentage			8.00%
Subsequent Event [Member] | Promissory Notes [Member] | OWP Ventures Inc [Member]
Subsequent Event [Line Items]
Debt instrument, face value | $		$ 400,000
Debt maturity date		Jan. 1, 2024
Debt interest rate, percentage		8.00%